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Palavras Chave arrays de células, erros de tradução, tRNA, agregação proteica, resposta ao
stress, stress proteotóxico.
Resumo O stress proteotóxico resulta da acumulação de proteínas agregadas que des-
tabilizam a homeostase do proteoma (proteostase). As células respondem à
agregação de proteínas, induzindo e aumentando a expressão de chaperones
moleculares, que auxiliam as proteínas a re-adquirir o seu estado nativo, do
sistema ubiquitina-proteassoma e autofagia, que degradam estas proteínas.
Disfunção destas respostas celulares conduz frequentemente a doença.
Para clarificar a biologia do stress proteotóxico, expusemos células de leve-
dura a 32 condições fisiológicas diferentes e, utilizámos uma metodologia que
destabiliza o proteoma através da indução de erros de tradução do mRNA.
Estes estudos demonstraram que várias substâncias químicas (como cloreto
de cálcio, cloreto de cádmio, cloreto de lítio, cloreto de magnésio, trióxido de
crómio, geneticina, menadiona e temperatura elevada) e erros ribossomais
(incorporação incorrecta de serina nos codões dos restantes aminoácidos)
induzem a formação de agregados proteicos.
Os estudos mencionados acima foram realizados recorrendo a arrays de célu-
las. Os arrays de células são uma nova tecnologia com um número crescente
de aplicações, nomeadamente na identificação de determinantes genéticos
de doenças e nas relações dinâmicas entre células e o ambiente que as ro-
deia. São também uma ferramenta valiosa em estudos de análise de feno-
mas. Neste estudo, otimizámos esta nova técnica no nosso laboratório, de
modo a facilitar os estudos do stress proteotóxico em curso no nosso labora-
tório.

Keywords cell-arrays, mistranslation, tRNA, protein aggregation, stress response, pro-
teotoxic stress.
Abstract Proteotoxic stress is associated with the accumulation of aggregated proteins
in the cell. Cells respond to protein aggregation by inducting and up-regulating
the expression of molecular chaperones, which help refold other proteins back
into their native state, the ubiquitin-proteasome system and autophagy that
lead to their degradation. Malfunction of these cellular responses leads fre-
quently to disease.
In order to clarify the biology of proteotoxic stress, we have exposed yeast cells
to 32 physiological conditions and destabilized the proteome through riboso-
mal errors. The data show that many chemical stressors (namely, calcium
chloride, cadmium chloride, chromium trioxide, geneticine, lithium chloride,
magnesium chloride, menadione, and high temperature) and protein synthe-
sis errors (misincorporation of serine at 19 non-cognate codons) induce the
formation of protein aggregation.
The above studies were carried out using cell-arrays. This new type of ar-
rays has an increasing number of applications, namely in the identification of
genetic determinants of disease and in the study of the dynamic relationship
between cells and environment. It also has important advantages to study the
phenome. In order to advance our knowledge of proteotoxic stress we have
optimized this new technique in our laboratory during this MsC thesis project.
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Chapter 1
Introduction
This introduction is divided in three main topics, namely protein biosynthesis, protein
folding and misfolding and cell-arrays technology. It provides an overview of the main processes
involved in proteotoxic stress with a particular emphasis on protein biosynthesis. Protein
misfolding and aggregation is generally considered as being a post-translational process, but
it may also result from errors that occur during protein synthesis and we provide an overview
of the types of translational errors that may result in increased protein aggregation.
1.1 Biosynthesis of proteins
Translation is divided into four main steps: initiation, elongation, termination and recy-
cling. The goal of initiation is to position the ribosome at the start of the coding region, i. e.,
at the initiation codon of the mRNA with a methionyl initiator tRNA bound in the peptidyl
(P) site. Elongation of the peptide chain then begins with the selection of tRNAs in the ac-
ceptor (A) site, and then the ribosome catalyzes the formation of a peptide bond. The tRNAs
and mRNA are translocated, so that the next codon can be moved into the A-site. Termina-
tion occurs when a stop codon (UAA, UAG, or UGA) arrives at the active ribosomal A-site
and the finished peptide is then released from the ribosome. Finally, recycling involves the
separation of the ribosomal subunits, releasing the mRNA and the deacylated tRNA [38, 39].
These fundamental events sometimes differ between bacteria, eukaryote, and archaea [39].
The ribosomes are critical for protein synthesis. They consist of two subunits: the small
subunit (40S) and the large subunit (60S) (in eukaryotes) [70], and have three decoding sites,
namely A-, P- and E- (exit) sites. The A- and P-sites participate in aminoacyl-tRNA (aa-
tRNA) selection and translocation. The E-site is an exit site for deacylated tRNA. Addition-
ally, the occupation of the E-site can change allosterically the affinity of the A-site during
selection of in-coming aa-tRNAs, so it influences decoding fidelity [58, 88]. The ribosome
experiments two conformational states during translation: pre-translocational state and post-
translocational state. The first one is characterized by high affinity for tRNA in A- and P-sites
and low affinity in the E-site, while in the second step the P- and E-sites have high affinity
for tRNA and the A-site has low affinity. Interestingly, transitions from one state to the other
occur when the previous low affinity binding site is occupied [23].
Gene expression is regulated at different levels, namely transcription of the gene into
mRNA, processing of the mRNA, transport of the mRNA from the nucleus to the cytoplasm,
binding of the mRNA to ribosomes, initiation, elongation and termination of translation,
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and processing of proteins to their final and functional conformation [50]. At the translation
level, the main control points is the initiation step, but elongation and termination are also
important.
1.1.1 Translation
Initiation
During transcription in the nucleus, mRNA looses its introns and acquires a cap structure
at its 5'-end and a poly(A)-tail at the 3'-end. The mature strand of RNA can be divided into
three domains, namely the 5'-untranslated region (5'-UTR), the region encoding the protein
(ORF − open reading frame), and the 3'-UTR or 3'-tail [38].
The initiation pathway begins when the eIF2·GTP·Met-tRNAi ternary complex is assem-
bled. The formation of this complex is assisted by eIF2B, in order to recycle the eIF2·GDP
complex after each initiation cycle: eIF2 is a G protein and has higher affinity for GDP than
GTP [39]. After the formation of eIF2·GTP·Met-tRNAi ternary complex, it binds to the small
ribosomal subunit (40S), forming the 43S complex. The formation of this complex is mainly
assisted by eIF1, eIF1A and eIF3 [12, 39]. The Met-tRNAi binds to the P-site of the ribosome,
in contrast to the delivery of specific aa-tRNA to the A-site of the ribosome during elongation
[13].
On the 5'-cap of the mRNA is assembled the eIF4F complex that opens secondary struc-
tures present in the 5'-UTR. Additionally, eIF4F, together with the poly(A)-binding protein
(PAB) bound to the 3'-poly(A) tail and eIF3, bring mRNA onto the 43S complex. This com-
plex scans the message in the 5' to 3' direction until the initiation codon is found, with the
help of eIF1 and eIF1A. As soon as the 43S complex finds the proper start AUG codon on the
mRNA it stops due to the interaction of the AUG codon with the anticodon of the initiator
tRNA in the ternary complex. This leads to the hydrolysis of GTP by eIF2, facilitated by the
GTPase-activating protein (GAP) eIF5. Then, eIF2·GDP releases the Met-tRNAi into the
P-site of the 40S subunit and dissociates from the complex, as well as eIF1, eIF1A, eIF3 and
eIF5 [39]. Simultaneously, eIF5B·GTP binds to the complex, and facilitates the binding of the
large ribosomal subunit (60S) (containing the peptidyl-transferase active site) to the 40S·Met-
tRNAi·mRNA complex, generating a translationally competent ribosome (Figure 1.1) [13, 39].
This event is the signal for GTP hydrolysis by eIF5B, followed by its dissociation from the
complex, due to the low affinity of the GDP-bound form for the ribosome [39].
Elongation
Translation elongation uses a highly conserved machinery across the three kingdoms of
life. The elongation of the peptide chain begins with a peptidyl-tRNA in the P-site of the
ribosome. An aminoacyl-tRNA is transferred from a ternary complex to the elongation factor
(eEF1A) [39]. This eEF1A·GTP·aa-tRNA ternary complex binds to the A-site of the ribosome
[1, 39]. In order to ensure that only the cognate tRNA is selected for the next stage of
elongation the codon-anticodon base pairing between the mRNA and the tRNA are checked
and conformational changes in the decoding center of the small ribosomal subunit and GTP
hydrolysis by eEF1A provide additional proofreading of that interaction. In the first step,
codon-anticodon base pairing induces a change in the conformation of three bases in the 40S
subunit in order to interact with the mRNA-tRNA duplex. This interaction is likely to activate
eEF1A's GTPase activity, resulting in the release of the aminoacyl-tRNA into de A-site by
2
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Figure 1.1: Pathway of translation initiation in eukaryotes. Red dots represent GDP
and green dots are GTP. More details described in the text. Adapted from [13].
eEF1A·GDP [1, 39]. Then, the formation of a peptide bond between the incoming amino
acid and the peptidyl-tRNA is catalysed by the ribosomal peptidyl transferase center of the
60S subunit. As a result a deacylated tRNA in a hybrid state is formed with its anticodon
in the P-site of the 40S subunit and its acceptor terminal in the E-site of the 60S subunit
of the ribosome. At the same time, the peptidyl-tRNA is in a similar hybrid conformation
with its anticodon in the A-site of the small subunit and its acceptor terminal in the P-site
of the large subunit. For progression of elongation, this complex is translocated so that the
3
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deacylated tRNA is in the E-site only, the peptidyl-tRNA in the P-site only, and the mRNA
moves three nucleotides downstream to place the next codon of the mRNA into the A-site.
These steps require elongation factor 2, which is responsible for the hydrolysis of GTP that
facilitates translocation. After the hydrolysis of GTP and the discharge of aminoacyl-tRNA
from the ribosome, eEF1A·GDP is also released and recycled to its GTP-bound form, mediated
by eEF1B (a multifactor complex), in order to participate in further cycles of polypeptide
elongation. This process is repeated until a stop codon enters the A-site, leading to the
beginning of the termination factors [39].
Termination
As referred above, the presence of a stop codon in the ribosomal A-site leads to the
termination of translation. Stop codons presented in the A-site are decoded by class 1 release
factors (eRF1, in eukaryotes). Class 2 release factors (eRF3, in eukaryotes) are GTPases that
stimulate the activity of eRF1 bound to the stop codon. In response to the activity of class 1
release factors, the peptidyl transferase center of the ribosome catalyses the hydrolysis of the
ester bond, linking the polypeptide chain to the P-site tRNA, which results in the release of
the completed polypeptide [39].
Recycling
The last stage of translation is the recycling of the ribosomal subunits, for another cycle
of translation. In eukaryotes, ribosome recycling requires eIF3, which binds to the small ri-
bosomal subunit opposite to the interface. In this way, eIF3 induces a conformational change
in the 40S subunit, increasing the rate of subunit dissociation and lowering the rate of associ-
ation. Another model for ribosomal recycling posits that termination and recycling may not
discharge the 40S subunit back into the cytoplasm, instead this subunit may be transferred
over or across the poly(A)-tail back to the 5'-end of the mRNA, mediated by the interac-
tion of eRF3 and PAB with initiation factor eIF4G. These events facilitate the reinitiation of
translation eliminating the need of the first initiation event [39].
1.1.2 tRNA and aminoacyl-tRNA synthetases
Transfer RNAs molecules have a fundamental role in protein synthesis. Indeed, tRNAs
decode codons (interact with mRNAs) and carry amino acids into the ribosome. Structurally,
tRNAs can be subdivided into families, according to the amino acid that they carry. The
tRNA species that are charged with the amino acid are called isoacceptor tRNAs [25, 41].
The secondary structure of tRNAs is highly conserved and form a cloverleaf structure
(Figure 1.2) [25, 41]. It consists of an acceptor stem, three stem-loops (or arms) and a
variable-loop, that are stabilized by hydrogen bonds between the stems. The stem-loops are
the dihydrouridine (D) loop, the anticodon-loop, and the TΨC-loop. Additionally, there are
specific nucleotides that are conserved in most tRNA species, and serve to stabilize tertiary
interactions that originate a three-dimensional structure, similar in all tRNA species. The
3'-end of tRNAs always ends up with the sequence CCA. The acceptor stem is formed by the
5'- and 3'-ends of the molecule, with seven base pairs followed by an overhanging unpaired
nucleotide at position 73 and the CCA. In protein synthesis, the amino acid is attached to the
ribose of the 3'-terminal A residue. The D-loop (8-11 bases) is on the left side, following a stem
of 3-4 base pairs. On the right side of the cloverleaf there's the 7-base TΨC-loop or T-loop,
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following a 5 base pair stem. Below the T-loop there is the variable-loop, which is the main
source of variability in tRNA structure and may contain 4 to 21 (or even more) bases. Finally,
at the bottom of the cloverleaf, following a 5 bp stem, is the anticodon-loop with 7 bases. The
anticodon, i. e. a 3-base sequence complementary to the codon that it decodes, is located
in the middle of the loop. The pairing of codon-anticodon occurs in an antiparallel fashion,
meaning that the 5'-anticodon base in the tRNA (nucleotide 34) pairs with the 3'-codon base
in the mRNA, and the 3'-anticodon base (nucleotide 36) with the 5'-codon base [25, 75].
Figure 1.2: tRNA structure. On the left, the crystallographic structure of yeast tRNAPhe
represents the global three-dimensional structure of tRNAs. The right panel shows the clover-
leaf secondary structure of tRNA. In red: amino acid accepting stem or aminoacyl-stem (AA);
in black: dihydrouridine stem and loop domain (DSL); in green: anticodon stem and loop do-
main (ASL); in gold: extra-loop (EL); and, in blue, the ribothymidine, or TΨC, stem and
loop (TSL). Adapted from [1].
There are two ways of producing aminoacyl-tRNAs: the direct acylation of tRNA by
aminoacyl-tRNA synthetases (aaRSs) and an indirect pathway of aminoacyl-tRNA synthesis.
The first one is an ATP-dependent reaction carried out by aaRSs that are very specific in
selecting amino acids and tRNAs. Each family of tRNA isoacceptors is recognized by an aaRS.
So, each of the 20 amino acids is recognized and activated by a specific synthetase [25, 68, 75].
These enzymes catalyze the first step in protein biosynthesis: the specific aminoacylation of
tRNAs, linking anticodons of tRNAs with specific amino acids [68, 75]. In this reaction, each
amino acid is attached to the 3'-end of its tRNA, forming an ester bond between the amino acid
and one of the hydroxyl groups of the terminal adenosine of the CCA end [75]. Alternatively,
tRNA-dependent amino acid modification, where the acylation of tRNA involves acylation by
a ‘precursor’ amino acid by a nondiscriminating aaRS, and then, this ‘precursor’ amino acid
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is converted to the correct amino acid. This conversion of the ‘precursor’ amino acid to the
correct one, matching the tRNA specificity, is mediated by a non-aaRS [89].
The aaRS can be divided in two distinct families: class I and class II (Figure 1.3) [68]. Class
I enzymes contain a Rossmann nucleotide-binding fold in the active site domain, composed of
alternating β-strands and α-helices. This class can be split into three subgroups (Ia, Ib, and
Ic), whose enzymes have a tendency to recognize amino acids that are chemically related. Class
II enzymes have in their active sites a seven-stranded β-sheet with flaking α-helices. These
enzymes can also be split into three subclasses (IIa, IIb, and IIc). Apart from the biochemistry
of the aminoacylation reaction both classes differ in several aspects. For example, proteins of
these two classes show little or no structural similarity, they have almost no structural motifs
in common, they acylate the amino acid to different hydroxyl groups of the terminal ribose of
the tRNA, and face the tRNA from different angles [68, 89].
Figure 1.3: The two subclasses of aminoacyl-tRNA synthetases. The ancestor of the
class I enzyme is GlnRS, whereas the ancestor of the class II enzyme is AspRS. Adapted from
[68].
1.1.3 Translation fidelity
Translation errors can emerge during tRNA charging by aaRSs and when the mRNA
is decoded by the ribosome. At the ribosome level, mRNA decoding can be affected by
four major types or errors: missence errors, which cause incorrect amino acid incorporation
into polypeptide chains, resulting in the synthesis of mutant proteins; nonsense errors, which
cause readthrough of stop codon, producing proteins with extended C-termini; frameshifting
errors that alter the mRNA reading frame, resulting in out-of-frame truncated proteins; and,
processivity errors that terminate translation prematurely, producing truncated proteins. In
terms of aminoacylation errors, these are mostly caused by the incorrect recognition of cognate
tRNAs by aaRSs or by inability of the aaRSs to differentiate between similar amino acids.
These errors are minimized by aaRSs editing mechanisms, responsible to reject incorrectly
bound amino acids, and by specific tRNA-aaRS interaction networks [57].
Aminoacyl-tRNA synthetase editing activities can occur either before and/or after the
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misactivated amino acid is attached to tRNA, known as pretransfer editing and posttransfer
editing, respectively. This editing activity, namely posttransfer editing, was first demonstrated
by Eldred and Schimmel and by Yarus [18, 48, 93]. In pretansfer editing, the hydrolysis of
misactivated aminoacyl adenylate (aa-AMP) occur before the aminoacyl moiety is transfered
to the 3'–end of tRNA. There are three main models to explain the mechanisms of pretransfer
editing: translocation, selective release, and active site hydrolysis models (Figure 1.4). In the
translocation model, near-cognate aa-AMP is synthesized at the active site but hydrolyzed
at the editing site. In the two other models, pretransfer editing involves selective release of
misactivated amino acids, which then undergoes spontaneous hydrolysis in solution, and/or
their hydrolysis in the active site, respectively [48]. Pretransfer editing is utilized for the
clearance of misactivated Ile by LeuRS, Ala by ProRS, Val by IleRS, and Ser by ThrRS [37].
In posttransfer editing, the 3'–end of mischarged aa-tRNAs moves from the active site to the
editing site, while the rest of the tRNA molecule remain attached to the aaRS (Figure 1.4).
In the editing site, the aminoacyl ester bond between non-cognate amino acid and tRNA is
deacylated. Posttransfer editing activities are associated with both class I and II aaRSs, IleRS,
ValRS, LeuRS, PheRS, ThrRS, ProRS, and AlaRS to eliminate non-cognate aminoacyl-tRNAs
[37, 48, 91].
As mentioned above, protein synthesis errors (mistranslation) can occur during initiation,
elongation and termination and have a major impact on yeast biology (Table 1.1), and most
likely in the biology of all organisms, but its relevance for protein misfolding/aggregation and
proteotoxic stress is still poorly understood.
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Figure 1.4: Editing mechanisms in aaRSs. (A) Pretransfer editing pathways in aaRSs.
The misactivated aa-AMP can be hydrolyzed in a tRNA-independent manner either through
the direct catalysis of aa-AMP hydrolysis by the aminoacylation active site (AS) before release
(pathway 1 − active site hydrolysis) or through selective release of non-cognate aa-AMP fol-
lowed by spontaneous hydrolysis in solution (pathway 2 − selective release). tRNA-dependent
pretransfer hydrolysis (pathway 3 − translocation of aa-AMP) can occur within the aminoacy-
lation AS in some aaRSs, or in the editing site (ES) presumably via translocation of aa-AMP
through a channel between AS and ES. (B) Posttransfer editing pathways in aaRSs. Mis-
charged aminoacyl-tRNA (aa-tRNA) can be hydrolyzed via translocation of the 3'-terminal
CCA of tRNA from the aminoacylation AS to the distal ES (pathway 1). Alternatively in
class II aaRSs, the mischarged aa-tRNA may be released into solution, then either resampled
by the aaRS (pathway 2) or hydrolyzed by an accessory trans-editing factor (pathway 3).
Adapted from [91].
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Table 1.1: Major effects of mistranslation in S. cerevisiae [55, 59, 73, 78].
Effects of CUG mistranslation in S. cerevisiae
- increased ploidy (up to 4N);
- large chromosomal rearrangements;
- blocking mating and sexual reproduction;
- altered sporulation;
- altered expression of molecular chaperones and carbohydrate metabolism;
- increased proteasome activity;
- up-regulation of cell wall structural proteins;
- down-regulation of protein synthesis and amino acid metabolism;
- alterations in genome and gene expression −→ phenotypic alterations:
- morphology and cell shape and size heterogeneous;
- formation of pseudohyphae and hyphae;
- increased resistance to several agents (e.g. nutrient starvation, cadmium, H2O2);
- accumulation of glycogen and trehalose;
- increased secretion of extracellular hydrolases: lipases and proteases;
- strong effect on cell adhesion.
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1.2 Protein folding and misfolding
After biosynthesis and in order to become functional newly synthesized polypeptide chains
are folded into compact structures, based on the information encoded in their amino acids
sequence [4, 15]. The term protein folding is universally recognized as the process responsible
for the acquisition of the native structure, starting from a completely or partially unfolded
state. This folding process, occurring within the cells of living organisms, is assisted by a
large number of auxiliary factors, including molecular chaperones and folding catalysts. These
auxiliary factors do not contribute with conformational information to the folding process or
form a part of the final biologically active structure, instead they enable polypeptide chains
to fold efficiently [4, 15, 66]. The idea that there is a unidirectional relationship between
the primary amino acid sequence of a protein and its final conformation was suggested by
Anfinsen with their work with the enzyme ribonuclease [3, 66]. These authors concluded that
the information encoded in the primary sequence of proteins is an important factor in the
folding process. There are various forces involved in the folding process, such as Van der Waals
force, electrostatic force, hydrogen bonding, and hydrophobic force, but there are evidences
that the hydrophobic force is the dominant one, determining the overall folded structure of
the protein [15, 66]. Protein folding is now considered a stochastic process and involves the
concept of an ‘energy landscape’ for each protein, with a finite number of possibilities for
proteins to misfold and adopt non-native states, still being transiently stable (kinetic traps)
[15, 66].
In vivo, some proteins fold while still attached to the ribosome. While other proteins fold
in the cytoplasm after release from the ribosome, or when they enter specific compartments,
such as the endoplasmatic reticulum (ER). Depending on the environment in which protein
folding takes place, the details of the folding process vary, although the basic principles are
maintained [14].
The term misfolding describes processes that result in the acquisition of a number of per-
sistent non-native interactions that affect protein's architecture and/or its properties, leading
many times to the formation of insoluble protein aggregates [15, 71]. As a result of the accu-
mulation of misfolded proteins in cells, proteotoxic stress is produced. This subtype of stress
can occur under a variety of conditions, including hypoxia, hyperthermia, and exposure to de-
naturing agents or drugs that inhibit chaperone or proteasome activities. If misfolded proteins
accumulate and aggregate above a certain threshold, proteotoxic stress can be toxic, likely be-
cause of the presence of oligomeric species that interfere with cellular processes [64, 71, 86].
Fortunately, living systems have elaborated strategies to prevent interactions of proteins with
other molecules prior to folding completion [15, 86]. One of these strategies is the use of
molecular chaperones that associate with unfolded protein chains, avoiding aggregation and
supporting a more efficient folding in an ATP-dependent manner [86]. Additionally, there are
folding catalysts, whose function is to accelerate potentially slow steps in the folding process.
Peptidylprolyl isomerases (PPI) and protein disulphide isomerases (PDI) are the most impor-
tant folding catalysts. The first ones amplify the rate of cis/trans isomerisation of peptide
bonds involving proline residues, and the second ones improve the rate of formation and reor-
ganization of disulphide bonds within proteins [14, 15]. Additionally, in cases of proteotoxic
stress, cells also activate an adaptive response, known as the heat shock response (HSR) [64].
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1.2.1 Protein aggregation
Protein aggregates are oligomeric complexes that arise from non-native interactions among
structured intermediates in protein folding or assembly. They have poor solubility in aqueous
or detergent solvents, aberrant sub-cellular or extracellular localization and non-native sec-
ondary structure [43]. There are different types of protein aggregates: ordered (or structured)
aggregates as amyloid fibrils, and disordered (or amorphous) aggregates as inclusion bodies
[21, 43]. In both cases, aggregates are insoluble and metabolically stable under physiological
conditions [43].
The formation and structure of protein aggregates imply specific intermolecular interac-
tions between hydrophobic surfaces of structural subunits in partially folded intermediates.
Thus, initial stages of aggregation involve the interaction between specific surface elements of
one molecule and hydrophobic surface areas of structural subunits of neighboring molecules.
When a high number of interactions occur, the formation of large aggregates is likely. It is
possible that these aggregates (dimmers and tetramers) are soluble initially, but the formation
of larger aggregates will tend to exceed the solubility limit [21].
Environmental stressors are not the only agents that lead to the formation of partially
folded intermediates and aggregation. Rather, mutations, RNA modifications and ribosomal
errors can also lead to differential destabilization of the native state relative to the partially
folded intermediate [21, 43]. So, the main factors that determine if a truly synthesized protein
will aggregate, and the rate and extent of the aggregation, are the amino acid sequence,
pH, temperature and ionic strength, concentration of the protein, presence of co-solutes (for
instance, denaturants), and the presence/absence of molecular chaperones [21].
Since protein aggregates are more stable than the intermediate conformers from which they
originate the destiny of misfolded proteins will be determined by kinetic competition for the
aggregated substrates between proteasomal degradation and aggregation into high molecular
weight oligomers [43].
1.2.2 Cellular quality control mechanisms
The production of aberrant proteins is common and cells require protein quality control
mechanisms (PQC) to handle aberrant proteins. Physiological and environmental factors can
also denature proteins and cells use PQC systems to recover them [71]. Therefore, protein
aggregates do not accumulate in unstressed cells, due in part to the PQC system which is able
to destroy aberrant proteins arriving from transcription and translation [43].
Aberrant or misfolded proteins are marked by PQC systems and targeted for degradation
via the ubiquitin-proteasome system (UPS) [71]. The nascent polypeptide chain in the ribo-
some needs help to reach its translation end, and many proteins (20-30%) also need assistance
to reach their folding state. Thus, the PQC network evolved to maintain cellular protein home-
ostasis or proteostasis, maximizing cellular protein folding capacity (by the chaperone system
and folding catalysts), minimizing intrinsic and extrinsic attacks and degradation of misfolded
proteins by proteases, the ubiquitin-proteasome (UPS), and the lysosome-autophagy systems,
in order to avoid any potential harmful effects in the cell [9, 47, 66].
The first evidence for the existence and function of molecular chaperones came from expo-
sure of cells to heat-shock. For this reason, many chaperones are known as Hsps (heat shock
proteins) [15, 47, 86]. Chaperones do not serve as template or code for misfolded proteins, but
help to avoid and reverse non-functional conformations; to facilitate co- and post-translational
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folding; and, to assist in assembly and disassembly of protein complexes [47, 56]. They often
support the folding process via cycles of substrate binding and release, regulated by ATPase
activity [4]. Transcriptional regulation of Hsps is controlled by specific transcription factors
(TF), namely RpoH and heat shock factor (HSF). Under non-stress conditions, these TF are
present in the cytoplasm as monomers bound to chaperones. Under stress, the presence of un-
folded proteins titrate chaperones that release the TF to trimerize, translocate to the nucleus
and bind their cis-regulatory elements [47]. Chaperones can act together and in synergy within
the chaperone network and with other PQC systems, namely the proteasome and lysosomal
degradation pathways [47]. And, interact momentarily with unfolded or partially folded inter-
mediates, covering hydrophobic surfaces from forming inappropriate intra- or intermolecular
contacts [43]. They are also involved in other cellular processes, including protein targeting,
regulation of translocation, degradation and signal transduction [4, 56].
Chaperones are divided into different families or classes, classified by size and function:
small hsp (sHSP), Hsp60 chaperones, Hsp70 chaperones, the ATP-dependent Hsp90 family,
and the ATPase Associated with diverse Activities (AAA+) family [47, 86].
Members of the sHSP family have a molecular mass <43 kDa and the capacity to maintain
the solubility of partially folded proteins through binding to protect their exposed hydrophobic
surface. The sHSP destabilize protein aggregates and ease their solubilisation, refolding, or
degradation, mediated by Hsp104 and Hsp70/40 chaperones.
The hsp60 chaperones facilitate protein folding using an isolated cavity, known as the
‘Anfinsen cage’ and are present in the mitochondria.
The Hsp70 chaperones are cytosolic but, in eukaryotes, are also present in organelles
such as mitochondria and the endoplasmatic reticulum. These chaperones need numerous co-
factors to work efficiently in the folding of nascent polypeptides and their assembly, refolding
of misfolded proteins, translocation of proteins through membranes into organelles and for
secretion, and controlling the function and life-time of signaling and regulatory proteins.
The ATP-dependent Hsp90 family has similar functions to the Hsp70 family avoiding
non-specific aggregation of generic proteins. Besides that, Hsp90 are involved in signal trans-
duction, cell cycle, meiosis, transport, secretion and chromatin remodeling, epigenetic gene
regulation and viral replication, together with several co-factors. Moreover, Hsp90 can medi-
ate conformational changes of folded proteins, in order to achieve their stabilization, activation
or degradation.
The Hsp104 proteins are members of the AAA+ family and are highly induced in response
to stress conditions, conferring tolerance to it. Their functions are to prevent misfolding and,
mainly, to disaggregate proteins [47].
The transition of folding intermediates to the native state is highly regulated by Hsp70
and ATP hydrolysis [56]. Interestingly, the different classes of molecular chaperones cooperate
in the cell, and all chaperones can suppress the aggregation of folding proteins. In this way,
all chaperones are overproduced simultaneously under stress conditions [86].
The ubiquitin-proteasome system is the other main PQC system and is involved in degrada-
tion of proteins (including short-lived, misfolded and damaged polypeptides) in an ubiquitin-
dependent manner. Ubiquitinated proteins (with at least four ubiquitin moieties) selectively
bind to the proteasome, which in turn unfolds and translocates them into a proteolytic cham-
ber where proteins are hydrolyzed into short peptide fragments. Deubiquitination enzymes
present in the proteasome convert ubiquitin chains into monomers that can be used in new
ubiquitination reactions. Beyond, its proteolytic function, ubiquitination may be involved
in membrane trafficking, cell-cycle progression, differentiation, synaptic plasticity, apoptosis,
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endocytosis, DNA repair and transcriptional regulation [6, 71].
At a level of higher complexity, there is a connection between the ubiquitin-proteasome
system and molecular chaperones. Indeed, some molecular chaperones are linked to the UPS,
bind to non-native proteins and mediate their refolding or degradation [6].
Additionally, protein degradation can occur in the vacuole of yeasts and in the lysosome
of mammalian cells, known as the lysosome-autophagy system. The vacuole/lysosome are
suitable for degrading larger and more complex substrates, including protein complexes and
organelles, extending protein degradation capacity of the proteasome. Particles destined for
autophagic degradation are engulfed by membrane to form autophagosomes, where proteases
can access their substrates for degradation [35, 43, 47].
1.2.3 Protein misfolding and disease
It is not surprising that the presence of unfolded or misfolded proteins will lead to diseases
[15]. Under stress, genes related to chaperones and the autophagy and ubiquitin proteasome
system (UPS) are abundantly expressed. However, this machinery capacity to deal with
protein aggregation is limited and saturation of these PQC systems allows for accumulation
of protein aggregates [56].
Misfolding and aggregation are identified as common molecular events for a large number of
human diseases. These diseases are known as conformational diseases and they are character-
ized by proteotoxic stress which disrupts various cellular functions [56]. Additionally, the most
typical feature of many of the aggregation diseases is the final deposition of aggregation-prone
proteins in the form of amyloid fibrils and plaques. Such deposits can form in vital organs,
such as brain, liver and spleen, or in the skeletal tissue, depending on the disease involved
[15]. Conformational diseases include CAG-repeat/polyglutamine (polyQ) expansion disease
(Huntington's disease, HD; Kennedy's disease; spinocerebellar ataxias, SCAs) and non-CAG
diseases (Parkinson's disease, PD; prion diseases, such as Creutzfeldt-Jakob disease, CJD;
amyotrophic lateral sclerosis, ALS; and, Alzheimer's disease, AD) [4, 56]. Each of these dis-
eases has the typical characteristic of an age-dependent onset and a progressive fatal clinical
course [56]. The appearance of self-associated folded states together with aggregation and
fibril formation can be toxic (but not always), and is often caused by mutations in the disease
proteins, resulting in cellular dysfunction and pathology [56].
Other examples of diseases associated to aberrant proteins are cystic fibrosis and hyper-
trophic cardiomyophaty [4]. There are also several protein deposition diseases that involve
non-ordered proteins deposits, such as inclusion body myositis, light-chain deposition disease
and cataracts [21]. A summary of the main diseases associated to protein aggregation is shown
in Table 1.2.
As referred before, the symptoms of many diseases associated with the expression of
aggregation-prone proteins begin later in life and this suggests that aged cells are more suscep-
tible to proteotoxic stress. On the one hand, with aging protein oxidation increases, leading to
the formation of protein aggregates. Also the functionality of the chaperone and proteasome
networks declines during aging. In this situation, there is an imbalance between the ever grow-
ing production of toxic misfolded species and the decreased protective capacity of the PQC
machinery [79, 85]. So, even in the absence of mutations in genes encoding aggregation-prone
proteins, cell aging and oxidative stress are sufficient to increase protein aggregates.
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Table 1.2: A summary of the main diseases associated to protein aggregation [4, 14,
80].
Clinical syndrome Proteins/peptides involved
Alzheimer's disease APP β-peptide
Scrapie/Creutzfeldt-Jakob's disease Prion protein
Polyglutamine expansion disease: Various polyQ proteins:
Huntington's disease Huntingtin
Dentatorubro-pallido-Luysian atrophy Atrophin 1
Cerebellar ataxias Ataxins
Kennedy disease Androgen receptor
Spino cerebellar ataxia 17 TATA box-binding protein
Familial amyloidosis Transthyretin/lysozyme
Cystic fibrosis CFTR
Familial hypercholesterolemia LDL receptor
Phenylketonuria Phenylalanine hydroxylase
MCAD deficiency Medium-chain acyl-CoA dehydrogenase
Hypertrophic cardiomyopathy Various sarcometric proteins
Osteogenesis imperfecta Collagens
Epidermolysis bullosa simplex Keratins
Hereditary spastic paraplegia Mitochondrial Hsp60
Desmin-related myopathy αB-Crystallin
Sanjad-Sakati and Kenny-Caffrey TBCE
Marfan syndrome Fibrillin
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1.3 Cell-arrays technology
Microarrays technology was developed in the early 1990's as a way to measure the transcrip-
tion levels of a set of genes simultaneously and became an effective tool for gene expression or
transcriptional analysis [65, 87]. This technique consists in arrayed nucleotide probes printed
onto the surface of glass slides for testing their degree of hybridization to the investigated
cell-derived cDNA [65, 67]. Some variants of DNA microarrays have been developed, namely
complementary DNA (cDNA) microarrays − double-stranded cDNA or PCR products spotted
on glass slides, and oligonucleotide microarrays [65]. This technology was expanded to protein
arrays for probing protein-protein or protein-small molecule interactions, in which pure pro-
teins are immobilized on the surface of a glass slide [87, 95]. Further developments expanded
the technology to carbohydrates, tissues, small-molecules and drug-like molecules [60, 87]. The
principle in all cases is the same: reactive molecules are fixed onto a mapped solid surface grid
and exposed to a multi-competent analyte mixture. There is diversity of arrayed molecules
and array formats as well as diversity of detection techniques, such as fluorescence, lumines-
cence, electrochemical detection, mass spectrometry, surface plasmon resonance and others
[5, 60]. As a consequence, array technologies can be used in a large number of applications
in medicine, biology, toxicology, drug screening, etc. [5]. In combination with bioinformatics
tools to process and analyse array data, this technology is widely used in systems biology,
genomics, transcriptomics and proteomics [60].
However, DNA arrays have limitations due to artifacts from RNA isolation and cross
hybridization, and protein arrays are difficult to produce because large numbers of individually
purified proteins are required, and it is unclear for how long the proteins remain stable once
the array is printed [95]. Additionally, to understand the role of genes with unknown function,
it is better to analyse phenotypes resulting from either gain or loss of function of each gene in
a global manner [10]. To address this problem, whole-cell arrays have been developed, namely
the LuxArray. This technology used a collection of 689 non-redundant functional promoter
fusions to Photorhabdus luminescens luxCDABE in live E. coli strains that were used to build
the array [5, 16]. Another cell-based microarray system for identifying the cellular functions
of gene products was described by Ziauddin and Sabatini. In this system, the array spots are
clusters of mammalian cells expressing defined DNA constructs, whose decrease or increase is
indicative of the function of specific gene products [95, 90]. So, cell arrays allow investigators
to identify genes implicated in various cellular processes, such as cell adhesion, apoptosis and
signal transduction [90].
Taking into account the usual cell-assaying methods (based in micro-well plate format),
cell microarrays also bring some additional advantages: they can hold at least 5000-6000 spots
in one slide (enabling a genome-wide screen on only a few slides); need small quantities of
expensive reagents, use limited biological samples, and allow for a larger range of detection
methods to be used [10, 20, 90]. However, this technology has some limitations, such as
cell stress, efficiency of transfection, flexibility of detection, etc. [10]. For instance, some
treatments used during production of cell arrays can be toxic to live cells, leading to stress.
Additionally, collection of high-content images of each spot, automated analysis of each image
and organization of the resulting data are issues that still need special attention in cell-
microarrays analysis [87].
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1.3.1 Types of cell-arrays
Cell-arrays technology can be divided in subtypes, namely positional cell microarrays and
batch or non-positional cell microarrays. In positional cell microarrays, cells are printed
directly onto a surface, in an arranged way, and preferentially attach to the arrayed substrates
(such as polymers, carbohydrates, antibodies, proteins from the extracellular matrix, etc.);
clusters of cells are physically separated and characterized by specific x and y coordinates. On
the other hand, batch arrays are non-positional arrays, and do not rely on x and y coordinates
to deconvolute the data. In this case, cells are encoded (ranging from a color code to a radio
frequencies code), phenotypes are assayed in batch and cells of interest are retrieved through
decoding [10].
There are also transfected cell-arrays, small interfering RNA (siRNA) cell-arrays and spot-
ted cell-arrays. In general, for constructing transfected-cell microarrays nanoliter quantities of
nucleic acids (cDNA in plasmid expressing vectors or linear PCR products designed to express
proteins of interest) are printed in defined locations onto the surfaces of glass slides, using a
robotic microarrayer. Before cells are added to the printed array, it can be treated with a
transfection reagent or a stable transfection reagent may be printed along with the nucleic
acid. In order to initiate transfection, cultured cells in medium are added to printed arrays
disposed in tissue culture dishes (few days in culture). The printed material is internalized
as cells adhere to the spots and become transfected. Cells that do not adhere to the spots
form a non-transfected lawn between spots. At the end of an experiment, the microarrays
are fixed and prepared for immunofluorescence, staining for DNA and F-actin, in situ hy-
bridization, chemiluminescence, autoradiography, apoptosis detection or other visualization
methods. The arrays are then covered with a cover slip and visualized with a microarray
scanner or fluorescence microscope to provide a view of the entire array area (Figure 1.5)
[65, 87, 90]. Ziauddin and Sabatini called this method ‘reverse transfection’ because cells are
added on top of the nucleic acid instead of the opposite [87, 95]. This technique came as
a great promise for high-throughput characterization of cellular phenotypes, identification of
small molecule targets (for drug screening, for instance), and large-scale functional genomic
studies [29, 65, 95]. Nevertheless, transfected cell arrays still have some limitations, such as the
difficulty in obtaining high transfection efficiency in some cell lines, and getting the genomic
cDNA expression constructs [8, 29, 65]. Despite this, transfected cell arrays have already been
used to identify genes involved in chromosome maintenance, measuring response of neural
precursor cells to a multiplicity of extracellular matrix components, finding ubiquitin targets,
and detecting protein-protein interactions [29].
siRNA cell-arrays take advantage of RNAi's potential to silence genes selectively, producing
loss-of-function phenotypes for genetic studies. RNAi is a post-transcriptional gene silencing
process, in which double-stranded RNA triggers sequence-specific degradation of target mR-
NAs [87, 90]. The chemically synthesized small interfering RNAs are RNA duplexes containing
21 bp and 3' dinucleotide overhangs that are cleavage products of the Dicer enzyme. This
enzyme cleaves double stranded RNA precursor molecules into short interfering RNAs and
small temporal RNAs [90]. Cell microarrays using siRNA can considerably reduce the amount
of RNAi reagents and cells and improves the speed of high-throughput studies with RNAi
libraries [10, 87]. This technology is a subtype of transfected cell-microarrays, since mixtures
of siRNA-plasmid constructs, polymer and transfection reagent are arrayed onto a glass slide,
followed by deposition of cells onto the array and transfection of cells (Figure 1.5) [10, 53, 90].
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Figure 1.5: Schematic model of the three types of cell microarrays. Transfected cell-
microarrays: nucleic acids (such as expression plasmid or RNA) are printed on a standard glass
microarray and used to transfect cells with the addition of a transfection reagent. Cultured
cells in medium are added to the array, adhere to the spots and become transfected by inter-
nalising the nucleic acids. RNAi cell-microarrays: is a subtype of transfected cell-microarrays,
differing in the printing of RNAi onto glass slides to transfect cells. Spotted cell-microarrays:
a suspension of cells is printed onto coated glass slides by contact deposition, in an organized
manner. After printing, in the three types of cell-arrays, slides are treated to an efficient
screening of the arrayed cell population.
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The numerous phenotypes that result from specific gene knock-downs can be analyzed ei-
ther in living cells using gene expression reporters, labeled proteins or calcium fluxes with
calcium-sensitive fluorophores, or in fixed cells by in situ hybridization or immunostaining
[10]. Another advantage of this technique is that, as siRNA microarrays are a subtype of
transfected cell microarrays, these two categories of cell microarray can co-exist on the same
array, and the two species of constructs can be co-transfected, resulting in cell clusters that
overexpress and underexpress any genes of interest [90].
Finally, spotted cell microarrays (also named cell chips) are made by contact deposition of
suspensions of cells onto coated glass slides using a printing arrayer and imaging the stained
subcellular features (Figure 1.5). Importantly, cells from a wide variety of cell types, growth
conditions, and treatments can be arrayed on a single slide. Spotted cell microarrays are a
high-throughput technology used for measuring cellular phenotypes, including cell morphology,
protein and RNA localization. This technique has some advantages in comparison with the
two deviations of cell arrays presented before, namely it avoids the laborious cDNA expression
or RNAi construct procedure and it is not limited to high-efficient transfections [29, 62, 65].
Spotted cell microarrays were first developed and applied for Saccharomyces cerevisiae and
bacteria to set up functional genomic screens [62, 94]. Protocols to print human cells have
also been described by Hart and colleagues [29].
1.3.2 Imaging cell-arrays
Analysis of cell microarrays requires automation: high-throughput image acquisition and
automated image analysis. To achieve this, there are two different types of systems: microarray
scanners (low-resolution image of an entire slide), and motorized microscopes (high-resolution
readout). Depending on the resolution required to visualize phenotypes of interest, an appro-
priated system must be selected. For instance, when a low-resolution assay for phenotypes
(such as cell growth, death or total amount of protein) is intended, it may be reasonable to
acquire an image with a high-resolution microarrays scanner. On the other hand, in order to
visualize the phenotype of interest, at a subcellular level, high-resolution images are often re-
quired, using, in this case, microscopes outfitted with motorized components. However, these
microscope-derived instruments have been designed to acquire images from multi-well plates
rather than cell microarrays, which poses a challenge to imaging cell microarrays [87].
1.3.3 Potential uses of cell-arrays
Cell microarrays have advantages over traditional methods, being an expressing-cloning
system for the high-throughput identification of genes of biological interest. For this purpose,
Ziauddin and Sabatini made a screen of 192 epitope-tagged cDNA clones in expression vectors,
which were printed and transfected without knowing the identities of each gene. Then, the
identification of genes that can affect specific cellular processes is made by probing the result-
ing cell arrays. In fact, through the analysis of cell clusters, they identified genes involved in
apoptosis (cell fragmentation), cell adhesion (by close juxtaposition of cell membranes), phos-
phorylation, and nuclear and cytosolic subcellular locations of epitope-tagged protein. This
study illustrated the diversity of cellular phenomena that becomes accessible to investigation
through cell arrays. Additionally, live cells could be analyzed for the subcellular distribution
of organelles, vesicular trafficking, protein translocation or calcium waves.
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In fact, cell microarrays offer great versatility since numerous experimental parameters can
be used in a combinatorial manner leading to a variety of potential applications. Variables
amenable by cell arrays include the substance arrayed, cell line, cell culture conditions, external
stimuli and assaying method [90].
Moreover, structure-function relationships of genes can be elucidated using cell arrays,
simply expressing collections of mutants of a particular gene on a cell array. In fact, signal-
transduction, cell adhesion, cell migration, and cellular chemotaxis studies take advantage of
this technology. In the specific case of signal transduction pathways, cell arrays are a robust
technique because signalling cannot be studied by DNA based methods due to the presence
of post-translational modifications and in vitro cell-free systems [8, 90]. Cell arrays have also
been used to study diseases and for drug screening [10, 90]. For instance, cell microarrays
can express combinations of cDNA and siRNA constructs for candidate oncogenes and tumor-
suppressor genes, in order to enlighten genetic criteria for tumor formation [90]. Relatively
to drug screening, cell arrays are useful to evaluate potential drug targets and to characterize
their effect in cells in a high-throughput manner [10].
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1.4 S. cerevisiae as a model system
Model organisms are essential to study human diseases, in particular to discover the basic
mechanisms underlying diseases, without ethical and experimental limitations [40, 66]. In
this work, we have chosen S. cerevisiae as a model organism, because it is an eukaryote, its
genome can be easily manipulated, grows rapidly as dispersed cells in culture, replica plating
and mutant isolation are simple, has a well-defined genetic system, and an adaptable DNA
transformation system. Yeasts are also suitable as model organisms for the study of basic
molecular mechanism underlying human diseases, such as neurodegenerative diseases, because
many of the cellular and biological processes are highly conserved from yeast to humans,
such as cell division, DNA replication and recombination, mismatch repair, protein folding,
intracellular transport, and metabolism [40, 66, 76]. Unlike most other organisms, strains of
S. cerevisiae have both a stable haploid and diploid state, and so recessive mutations can be
easily identified in haploid strains.
The S. cerevisiae genome was the first eukaryotic genome to be fully sequenced (1996),
and its strains are viable with a large number of markers. S. cerevisiae contains 16 well-
characterized chromosomes (haploid set), with 200 to 2200 kb in size. The complete genome
sequence of S. cerevisiae includes about 5750 open reading frames (ORFs), which represent
72% of the total genome sequence. Additionally, the yeast genome contains some 120 ribosso-
mal RNA genes (chromosome XII), 40 genes encoding small nuclear RNAs (smRNAs), and 262
tRNA genes. The yeast genome is highly compact, in contrast with those of its more complex
relatives in the eukaryotic world. With this combination of properties, yeast allows one to
perform genetic manipulations and to screen for induced phenotypes of relevance to human
diseases. Furthermore, plasmids can be introduced into yeast cells as replicating molecules or
to achieve DNA integration into the genome [24, 66, 76].
Many human genes related to disease have orthologues in yeast [40, 76], and many S. cere-
visiae proteins share high amino acid sequence similarity with human proteins. Furthermore,
several drugs act upon orthologous yeast proteins of human targets of specific diseases [66].
This model organism has been used with success by many researchers, to identify new
genes and pathways involved in tolerance to radiation, oxidative stress, human mitochondrial
disease, and to typify the effects of pharmacological agents, among others. In these studies,
a collection of gene deletion mutants of Saccharomyces cerevisiae, developed by the Saccha-
romyces Genome Deletion Project, was used [66].
However, one must be aware that, at least in some studies, as in the study of neurodegen-
erative diseases, the use of yeast as a model organism may not be adequate. It so, the results
obtained with yeast models of neurodegeneration have to be validated with human cells.
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1.5 Principal objectives of this thesis
The objective of this thesis was to optimize a yeast cell array to identify new genes and
environmental stressors that influence the formation of protein aggregates. We have tested
various glass slides and reagents and we were able to produce high quality yeast arrays. These
arrays were then used as a proof-of-principle to determine whether various chemicals and
ribosomal errors would increase the formation of protein aggregates. The results obtained
show that our methodology can be used to advance knowledge in the proteotoxic research
field.
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Material and Methods
2.1 Yeast strains and growth conditions
S. cerevisiae strains used were BY4741 (MATa his3∆0 leu2∆0 met15∆0 ura3∆0), S288C
(MATα SUC2 gal2 mal mel flo1 flo8-1 hap1 ho bio1 bio6), W303 (MATa/MATα leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 [phi+]), BMA64 (MATa/MATα ura3-52/ura3-52;
trp1∆ 2/trp1∆ 2; leu2-3,112/leu2-3,112; his3-11/his3-11; ade2-1/ade2-1; can1-100/can1-100),
CEN.PK2 (MATa/α ura3-52/ura3-52 trp1-289/trp1-289 leu2-3_112/leu2-3_112 his3 ∆1/his3
∆1 MAL2-8C/MAL2-8C SUC2/SUC2), EC1118 (Wine yeast HO/ho SUC/SUC MAL/MAL/
gal/gal), RM11-1a (MATa leu2∆ ura3∆ ho::Kan), BY4743 (MATa/MATα his3∆1/his3∆1
leu2∆0/ leu2∆0 met15∆0/MET15 LYS2/lys2∆0 ura3∆0/ura3∆0) and transformed BY4743
(with GFP fusion protein). All yeast strains were grown at 30 ◦C in YPD medium (glucose:
2% (w/v), yeast extract: 0.5% (w/v), and peptone: 1% (w/v)) (Formedium) and minimal
medium (glucose: 2% (w/v), yeast nitrogen base without amino acids: 0.67% (w/v), each
required amino acids (100 µg/ml)) (Formedium). BY4743 transformed cells were grown in
MM-Leu-His and preserved at -80 ◦C in MM-Leu-His + 40% (v/v) glycerol. Solid media were
performed by addiction of 2% agar (Formedium). All media were sterilized by heat in an
autoclave.
2.2 Cell-arrays: protocol optimization
Yeast cell arrays were produced using coated glass-slides and contact high density printing.
This technique was firstly described by Narayanaswamy and colleagues (2006), and we started
replicating their protocol for yeast cell-array printing, but without acceptable results. We
then decided to test all variables of the protocol in a systematic manner, in an attempt to
optimize it for our working conditions. In the next 2 sections we describe in detail how each
step was tested and the protocol optimized. Printing was carried out using a High Throughput
Automated Microarrayer (Microgrid Compact II), using Whole Cell Microarray Printing Pins
with 1.25 µl uptake loading volumes (Arrayit®), which were washed between printing runs.
The resulting spots are ∼220 µm in diameter, spaced 0.7 mm apart. In a standard print run,
the pins are washed in mQ water and dried 3 times by high velocity vacuum after each loading
and printing step. All the slides were visualized using an epifluorescence up-right microscope
Imager.Z1 (Zeiss), equipped with Brightfield filter and an oil-immersion objective, 63X.
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2.2.1 Slides preparation
Cell arrays were tested on different glass microscope slides, namely poly-L-lysine and con-
canavalin-A coated slides prepared in the lab, Poly-prep™ slides (Sigma-Aldrich™), Menzel-
Glaser Superfrost® Plus Gold (Thermo Scientific∗), SuperEpoxy 2 (Arrayit® Corporation)
and Hydrogel coated substrate − NEXTERION® Slide H.
For preparing poly-L-lysine coated slides we used 1 mg/ml and 10 mg/ml solutions of poly-
L-lysine (Poly-L-lysine solution: 0.1% w/v, in water; Sigma-Aldrich™) in phosphate buffered
saline 1X (1X PBS). Superfrost microscope slides (Cole-Parmer®), pre-cleaned, were immersed
in each of the solutions and mixed on an orbital shaker (50 rpm) for 30 minutes. Then, slides
were washed 3 times in fresh MilliQ water each time (plunging slides up and down 20 times),
centrifuged at 200 rpm for 3 minutes, and dried in a 50 ◦C oven for 30 minutes. This protocol
was adapted from several protocols for coating glass microscope slides with poly-L-lysine
(http://cmgm.stanford.edu/pbrown/protocols/; http://www.sysbio.harvard.edu/csb/resour-
ces/resources/downloads/Bauer_Core_ Polylysine_Protocol.doc).
Concanavalin-A-coated slides were prepared by immersing pre-cleaned slides (Superfrost
microscope slides; Cole-Parmer®) in a 0.1 mg/ml solution of ConA (Concanavalin A type VI
(lectin), lyophilized powder; Sigma Aldrich™) in 1X PBS during 15 minutes. Then, slides
were dried at room temperature for 1 hour, washed 2 times in fresh MilliQ water each time
(plunging slides up and down 10 times), and dried at room temperature for a second time. This
type of coated slides requires activation of ConA by adding CaCl2 (20 mM) and MnSO4 (20
mM) to cells prior to printing. This protocol was adapted from [62] and from other protocols
(http://jura.wi.mit.edu/sabatini_public/fly_array/conA.htm).
2.2.2 Cell-arrays printing
Glass slides and cell preparation for printing
For printing cell-arrays, we tested different coated glass slides (see above). Besides that,
we have also tested printing non-fixed and fixed cells, and different cell suspension solutions:
MilliQ water, MilliQ water plus 7% glycerol, MilliQ water plus 17% glycerol, MilliQ water
plus 27% glycerol, minimal medium (MM), MM plus 7% glycerol, MM plus 17% glycerol,
MM plus 27% glycerol, 1X PBS, 1X PBS plus 7% glycerol, 1X PBS plus 17% glycerol, 1X
PBS plus 27% glycerol, and sorbitol 0.5 M, 1 M and 1.5 M (Table 2.1). For fixation, cells
were incubated in 3.7% formaldehyde for 1 hour at room temperature, and washed with the
respective suspension solution.
Printing was performed using a High Throughput Automated Microarrayer (MicroGrid).
Again, in order to promote the adherence of cells to the slide surface, the slides were cen-
trifuged flat at 1500 x g during 5 minutes. We also tested whether variation in centrifugation
temperature (4 ◦C, 12 ◦C and 20 ◦C) influenced the adherence of cells to the slide surface.
Before microscopy analysis slides were washed and definitive preparations were obtained
using mounting media (Fluorshield™, Sigma-Aldrich). Washing is necessary to remove glycerol
and sorbitol that inhibit evaporation and enhance the brightness of each spot during printing.
Since we had spots with and without glycerol and sorbitol and cells suspended in different
media, we tested the washing step with MilliQ water, 1X PBS and 95% ethanol.
Slides were visualized as described above and cells were counted manually. As routine
practice, on average, 470 cells of 3 independent spots were analysed per experiment.
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Table 2.1: Conditions tested for the production of high density yeast cell-arrays.
Coated Slides Cells suspension Slide washing
Poly-L-lysine mQ water mQ water
Concanavalin-A mQ water + glycerol 7% PBS 1X
SuperEpoxy 2 mQ water + glycerol 17% Ethanol
Hydrogel mQ water + glycerol 27%
Superfrost plus gold MM
MM + glycerol 7%
MM + glycerol 17%
MM + glycerol 27%
PBS 1X
PBS 1X + glycerol 7%
PBS 1X + glycerol 17%
PBS 1X + glycerol 27%
Sorbitol 0.5 M
Sorbitol 1 M
Sorbitol 1.5 M
Effect of cell density on imaging
Cell density is critical to have spots where cells are not overlapped and are distributed
over the entire area of the spot.
We started with 1.26x109 cells/ml (in MilliQ water) in the first well, followed for 7 serial
dilutions of 1:2. For this, we used cells fixed as previously described and counted with the
TC10™ Automated Cell Counter (BioRad).
After printing, poly-L-lysine (1 mg/ml) slides were centrifuged flat at 1500 x g for 5
minutes, washed with 1X PBS and mounted with mounting media (Fluoroshield™). The slides
were visualized as described previously. Cells were counted manually. On average, 285 cells
of 3 independent spots were analysed.
Aging of the cell arrays and fluorescence quality
The literature available about cell arrays does not clarify whether aging of the slides
improves or degrades imaging quality [62, 60]. So, we perform an assay using a commercial
poly-L-lysine slide (aged) and fresh coated poly-L-lysine (1 and 10 mg/ml) slides. After
printing fixed cells in each slide, the array was treated as described above and analysed. We
also tested coated-slides made in house after 8 and 30 days of coating. All slides were visualized
on the day they were printed, as described previously. On average, 900 cells of 5 independent
spots were analysed.
The yeast BY4743 strain used in this assay expresses a GFP fusion protein which allowed
us to quantify cell fluorescence. The presence of fluorescent foci in cells was verified and the
number of cells with such foci was counted manually. On average, 340 cells of 3 independent
spots were analysed.
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2.2.3 Effect of strain genotype and growth conditions on cell adhesion
Finally, we have tested whether the genotype of the yeast strains influenced binding to the
glass slides. For this, we performed an assay with different yeast strains grown in 2 different
media: rich (YPD) and minimal media. Yeast cells were fixed with 3.7% formaldehyde,
and, then, printed onto poly-L-lysine-coated slides (1 mg/ml). After printing, slides were as
described above and, on average, 350 cells of 3 independent spots were analysed.
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2.3 Proteotoxic stress models
In order to check the reproducibility and feasibility of the cell-arrays technology to set up
high throughput screens to identify genes involved in protein aggregation, we used ribosomal
infidelity to destabilize the yeast proteome, which accelerates the formation of protein aggre-
gates. Additionally, we have investigated the effect of various chemical stressors in promoting
the formation of protein aggregates in yeast.
2.3.1 Plasmids
Previous studies in our laboratory have shown that misreading tRNAs can be used to
destabilize the proteome [77]. We have taken advantage of such tRNAs cloned into the yeast
single copy pRS315 vector, yielding the plasmid pUA261. New plasmids carrying mutant
misreading tRNA genes were also constructed by site directed mutagenesis (SDM) so that a
variety of codons can be mistranslated. The plasmids used are described in Table 2.2.
Table 2.2: Description of the plasmids used.
Plasmid Description
pRS315 Plasmid of 6018 bp containing the AmpR and LEU2 gene, allowing for
selection of transformants in LB media with ampicilin or in yeast MM-
Leu media, respectively. It is a single-copy vector.
pUA261 pRS315 plasmid containing one copy of C. albicans tRNAUGASer gene
cloned between BamHI and SalI restriction sites. For tRNAUGASer(Ser)
expression in S. cerevisae.
pUA262 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACAG(Leu)Ser. For single-copy expression of
mutant mistranslating tRNASer(Leu) in S. cerevisiae.
pUA263 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAGUA(Tyr)Ser. For single-copy expression of
mutant mistranslating tRNASer(Tyr) in S. cerevisiae.
pUA264 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAUUU(Lys)Ser. For single-copy expression of
mutant mistranslating tRNASer(Lys) in S. cerevisiae.
pUA265 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACGU(Thr)Ser. For single-copy expression of
mutant mistranslating tRNASer(Thr) in S. cerevisiae.
pUA266 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACAC(Val)Ser. For single-copy expression of mu-
tant mistranslating tRNASer(Val) in S. cerevisiae.
Continued on next page
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Table 2.2 – Continued from previous page.
Plasmid Description
pUA267 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAUAU(Ile)Ser. For single-copy expression of mu-
tant mistranslating tRNASer(Ile) in S. cerevisiae.
pUA268 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAUGC(Ala)Ser. For single-copy expression of
mutant mistranslating tRNASer(Ala) in S. cerevisiae.
pUA269 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAUCC(Gly)Ser. For single-copy expression of
mutant mistranslating tRNASer(Gly) in S. cerevisiae.
pUA801 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACCU(Arg)Ser. For single-copy expression of
mutant mistranslating tRNASer(Arg) in S. cerevisiae.
pUA802 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAAUG(His)Ser. For single-copy expression of mu-
tant mistranslating tRNASer(His) in S. cerevisiae.
pUA803 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACUC(Glu)Ser. For single-copy expression of
mutant mistranslating tRNASer(Glu) in S. cerevisiae.
pUA804 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAGCA(Cys)Ser. For single-copy expression of
mutant mistranslating tRNASer(Cys) in S. cerevisiae.
pUA805 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAAAA(Phe)Ser. For single-copy expression of
mutant mistranslating tRNASer(Phe) in S. cerevisiae.
pUA806 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACCA(Trp)Ser. For single-copy expression of
mutant mistranslating tRNASer(Trp) in S. cerevisiae.
pUA807 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAAUU(Asn)Ser. For single-copy expression of
mutant mistranslating tRNASer(Asn) in S. cerevisiae.
pUA808 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACUG(Gln)Ser. For single-copy expression of
mutant mistranslating tRNASer(Gln) in S. cerevisiae.
Continued on next page
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Table 2.2 – Continued from previous page.
Plasmid Description
pUA809 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNACAU(Met)Ser. For single-copy expression of
mutant mistranslating tRNASer(Met) in S. cerevisiae.
pUA810 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAAGG(Pro)Ser. For single-copy expression of
mutant mistranslating tRNASer(Pro) in S. cerevisiae.
pUA811 Plasmid constructed by SDM of the anticodon of tRNAUGASer gene
(pUA261) to originate tRNAAUC(Asp)Ser. For single-copy expression of
mutant mistranslating tRNASer(Asp) in S. cerevisiae.
2.3.2 Transformation of yeast cells
The transformation of yeast was performed using the LiAc/SS Carrier DNA/PEG method
[22]. Yeast cells were inoculated onto minimal medium (MM-His) and incubated overnight
at 30 ◦C, with 180 rpm shaking, until an OD600 of 0.4-0.5. Cells were then centrifuged (5000
rpm; 1 minute) in 1.5 ml microcentrifuge tubes. The supernatant was discarded and the
transformation reagents were added to the pellet in the following order: 240 µl PEG 3500 (50%
[w/v]), 36 µl 1.0 M LiAc, 50 µl boiled single-stranded carrier DNA (2.0 mg/ml), and 34 µl of
an aqueous solution of the plasmid of interest (containing 0.5-4 µg plasmid). Microcentrifuge
tubes were vortexed until a homogeneous suspension was obtained, followed by incubation at
42 ◦C for 40 minutes, in a Thermomixer comfort (Eppendorf). Cells were then centrifuged
at maximum speed for 1 minute, the transformation mixture (supernatant) was discarded,
and pellets were carefully resuspended in 200 µl of sterile mQ water. Each cell suspension
was plated in selective medium plates (MM-His-Leu) and incubated at 30 ◦C, until isolated
transformant colonies were visible (2-4 days).
2.3.3 Determination of protein aggregates
In order to visualize protein aggregates, we used a diploid BY4743 strain expressing an
Hsp104-GFP fusion protein, constructed previously in our laboratory. For this, the GFP tag
was fused inframe to the C-terminal coding region of the Hsp104 gene. The plasmid pKT128
(pFA6a-GFP(S65T)-His3MX) was used as a template for GFP amplification by PCR. This
plasmid contains the Schizosaccharomyces pombe his5 gene as transformation marker and can
be used in Saccharomyces cerevisiae for selecting positive clones. Cells containing the GFP
fusion protein were transformed with the mutant misreading tRNAs using single-copy plasmids
(Table 2.2), and positive transformants were selected in minimal medium lacking His and Leu.
Yeast cells were grown up to middle exponential phase in 96-well plates and were then fixed
with 3.7% formaldehyde for 1 hour at room temperature and washed (2x) in mQ water. These
cells were printed onto a poly-L-lysine-coated slide (home made, with 1 mg/ml) using a High
Throughput Automated Microarrayer (MicroGrid), and slides were centrifuged flat at 1500 x g
and 12 ◦C for 5 minutes, washed in 1X PBS and mounting media (Fluoroshield™) was applied
to them. Slides were then visualized using an epifluorescence up-right microscope Imager.Z1
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(Zeiss) equipped with 38 HE GFP and Brightfield filters and an oil-immersion objective, 63X
(Zeiss). The presence of fluorescent foci in cells was checked and their number was counted
manually. On average, 950 cells of 5 independent spots were analysed.
2.3.4 Stress conditions
The effect of chemical stressor on the formation or mitigation of protein aggregates, was
tested using the Saccharomyces cerevisiae BY4743 strain transformed with pRS315. Yeast
cells grown overnight were transferred to a 96-well plate at an optical density of 0.25 and
incubated with MM-Leu-His as a control or MM-Leu-His supplemented with the stressors
indicated in Table 2.3. Cultures were incubated for 20 hours at 30 ◦C, or 37 ◦C (when high
temperature was the stressor). For each condition, three clones of BY4743 strain with pRS315
were tested. After 20 h incubation, yeast cells were fixed with 3.7% formaldehyde for 1 hour at
room temperature and washed (2x) in mQ water. The suspension of cells were printed onto a
poly-L-lysine-coated slide (home made, with 1 mg/ml) using a High Throughput Automated
Microarrayer (MicroGrid), and slides were centrifuged flat at 1500 x g and 12 ◦C for 5 minutes,
washed in 1X PBS and mounting media (Fluoroshield™) was applied to them. Slides were
visualized using an epifluorescence up-right microscope Imager.Z1 (Zeiss) equipped with 38
HE GFP and brightfield filters and an oil-immersion objective, 63X (Zeiss). The presence of
brilliant dots in cells was checked and their number was counted manually. Moreover, total
fluorescence of cells was quantified using Image J. On average, 290 cells of 4 independent spots
for each of the three clones were analysed.
Table 2.3: List of chemical stressors and respective concentrations used.
Stress compound Concentration
Arsenic trioxide 0.4 mM
Caffeine 2 mM and 10 mM
Calcium chloride 0.5 M and 0.75 M
Cadmium chloride 50 µM and 100 µM
Copper sulfate 2.5 mM
Chromium trioxide 0.2 mM and 0.5 mM
DTT 4 mM and 12 mM
Ethanol 2% and 5%
Geneticine 75 mg/l and 200 mg/l
Guanidine hydrochloride 3 mM
Hydrogen peroxide 5 mM and 10 mM
Lithium chloride 150 mM and 300 mM
Magnesium chloride 1 M
Menadione 10 µM, 90 µM and 150 µM
Paraquat 80 µg/ml
Potassium chloride 1 M
Sodium chloride 0.5 M and 1 M
SDS 0.01% and 0.015%
High temperature 37 ◦C
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Cell-arrays: Protocol optimization
3.1 Overview
We have optimized a method to print high density cell arrays which is based on contact
printing technology developed for DNA and protein microarrays.
There is an increased need to miniaturization and parallelization of cell analysis methods,
to achieve high throughput in the shortest and cheapest period of time. In this way cell arrays
offer reduced assay volume and increased assay density. In fact, each spot of the array is
treated as an independent experiment and, since typical spot sizes and spacings are hundreds
of micrometers, this allows thousands of spots to be printed per slide. This high density of
spots per slide is then quantified using automated microscopy and image-based analysis.
Since the first description of cell arrays, they have been applied to a wide variety of bio-
logical applications, as an experimental platform for miniaturizing and parallelizing genome
wide gain- and loss-of-function studies. Therefore, this emerging technology offers opportuni-
ties to discover modulators of cellular function, identify genetic determinants of disease, and
understand the complex and dynamic relationships between cells and their local environments
[92].
In this chapter, we describe the optimization of a spotted cell array method based on the
work of Narayanaswamy and colleagues (2006).
3.2 Results
3.2.1 Glass slides and cell preparation for printing
In order to optimize binding of yeast cells to coated glass slides, we have tested 5 differ-
ent surfaces, namely: Poly-L-Lysine coated slide, Concanavalin-A-coated slide, SuperEpoxy
Substrates; Hydrogel coated-Substrates and Gold substrates. These slides were tested simul-
taneously with fixed and non-fixed yeast cells, different cell suspension solutions and three
different slide washing conditions (Material and Methods 2.2.2) (Figure 3.1 and Figures A.1-
A.10, Appendix A).
Poly-L-lysine-coated glass slides are used to fabricate DNA and protein microarrays. In
the latter case, proteins are immobilized non-covalently into the slides surface by printing
proteins in PBS. For cell-arrays, poly-L-lysine promotes adherence of yeast cells to the slide
surface by electrostatic interactions [62, 60].
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Figure 3.1: Heat-map of the percentage of imageable cells obtained from the dif-
ferent conditions tested for the yeast cell-arrays protocol optimization. In each
column shows the percentage of imageable cells obtained with the different slide washing con-
ditions (H2O, PBS and EtOH − ethanol) and different coated glasse slides (Poly-L-lysine,
Concanavalin-A, SuperEpoxy 2, Hydrogel, and Superfrost Plus Gold slides). Each row repre-
sents one of the different conditions used in the suspension of cells.
Our results show higher percentage of high quality imageable cells in poly-L-lysine-coated
slides, but only when cells are fixed and suspended in media without glycerol or sorbitol prior
to printing, and washed with 1X PBS (Figure 3.1). In contrast, almost all spots of cells treated
with glicerol or sorbitol had few or no cells, or the percentage of imageable cells was very low.
Printing of non-fixed yeast cells onto poly-L-lysine-coated slides showed higher percentages of
imageable cells in spots corresponding to cells treated without glycerol or sorbitol, and slides
washed with 1X PBS (Figure A.2, Appendix A).
Concanavalin-A-coated slides are also used to fabricate cell arrays, because lectin binds to
mannose residues in the yeast cell wall [62]. We have also used concanavalin-A as a substrate
for producing cell arrays (Figure 3.1 and Figures A.3 and A.4, Appendix A), however the
percentage of imageable cells was lower than that obtained with poly-L-lysine slides. As with
poly-L-lysine, several printing conditions were tested, but the general trend was lower adhesion
of cells to the concavalin-A substrate.
SuperEpoxy slides were produced initially for protein-microarrays, because epoxy groups
bind proteins covalently in several different ways and high number of amino acids reactive
groups can be captured on this surface, namely primary amines, thiol and hydroxyl groups
(http://arrayit.com/Products/Microarray_Slides/Epoxy_Slide/epoxy_slide). However, we
were not able to identify binding conditions which would promote efficient adhesion of yeast
cells to SuperEpoxy slides (Figure 3.1 and Figures A.5 and A.6, Appendix A).
NEXTERION® Slide H is used for printing protein microarrays by covalent immobilization
of peptides and proteins. The coating of this slide consists of a cross-linked polymer layer ac-
36
CHAPTER 3. CELL-ARRAYS: PROTOCOL OPTIMIZATION
tivated with N-Hydroxysuccinimide (NHS) esters to provide covalent immobilization of amine
groups. The terminal amino of amino-modified nucleic acids and glycans react irreversibly
with the NHS-ester groups to form a covalent bond. Proteins and other biomolecules bind via
amine-groups exposed on their surfaces (http://www.us.schott.com/nexterion/english/pro-
ducts/coated_slides/thin_film.html). Our data showed that this is not a suitable substrate
for production of yeast cell-arrays, because the percentage of imageable cells was low in all
conditions tested (Figure 3.1 and Figures A.7 and A.8, Appendix A).
Gold substrates are also used to produce DNA and protein-microarrays. Thermo Scientific∗
Superfrost Plus Gold Slides are made with an advanced adhesive technology and are specifically
designed for frozen tissue sections (http://www.menzel.de/Adhesion_Slides.678.0.html?L=1).
However, our data showed that this substrate is not adequate for producing yeast cell arrays
since binding of yeast cells to it was low in all conditions tested (Figure 3.1 and Figures A.9
and A.10, Appendix A).
Our data show differences between fixed and non-fixed cells. In particular, significant
differences were observed in the percentage of localized GFP foci between fixed and non-fixed
cells (Figure A.11-A.20, Appendix A), suggesting that the protocol used for slide definitive
preparations could introduce stress in the cell and promote formation of protein aggregation.
In order to verify this issue we have analysed GFP distribution in fixed and non-fixed cells
in fresh slides (without mounting media) and in definitive preparations of the slides (Figure
3.2 and Figure 3.3). There was a significant increase in the percentage of imageable non-fixed
cells, however it was attenuated in definitive preparations (with mounting) of fixed cells.
Figure 3.2: Effect of cell fixation and mounting on the percentage of imageable
yeast fixed and non-fixed cells. Data represent the mean ± s. d. of 5 independent images
(∗∗∗p<0.001 Unpaired t test with CI 95%).
With respect to fluorescence distribution, the differences between fixed and non-fixed cells
in definitive preparations (with mounting) was statistically significant, conversely to what was
observed in fresh preparations (Figure 3.3), suggesting that the mounting media stressed live
cells, leading to an increase of the presence of GFP foci and to decreased yeast cell survival.
We have also tested the effect of washing the glass slides with MilliQ water, 1X PBS and
95% ethanol prior to cell imaging, on the quality of the images. As the best results were
obtained with fixed cells suspended in media without glycerol and sorbitol, it is possible to
observe in detail the percentage of imageable cells in cells suspended in MilliQ water, 1X PBS
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Figure 3.3: Percentage of fixed and non-fixed yeast cells with GFP foci. Data
represent the mean ± s. d. of 5 independent images (∗∗∗p<0.001 Two-way RM ANOVA post
Bonferroni's test with CI 95%). Means are significantly different using or no mounting media
(Unpaired t test with CI 95%).
and MM, Figure 3.1 and in Figures A.21 to A.23, Appendix A.
The higher percentage of imageable cells was obtained with poly-L-lysine slides and fixed
cells resuspended in MilliQ water and 1X PBS, after slide washing with 1X PBS. The other
types of slides had a mean of percentages of imageable cells lower than 90% (p<0.05, Wilcoxon
Signed Rank Test with CI 95%).
Slides washing with MilliQ water produced the best results in concanavalin-A coated slides
with fixed cells resuspended in PBS. However, the mean of imageable cells was below 90%
(p=0.0495, Wilcoxon Signed Rank Test with CI 95%). In the other slide types, the mean of
imageable cells was below 60% (p<0.05, Wilcoxon Signed Rank Test with CI 95%).
Using ethanol as wash solution, in all slides, the mean of percentages of imagebale cells
was below 60% (p<0.05, Wilcoxon Signed Rank Test with CI 95%), indicating that ethanol
washing should be avoid.
Another parameter tested in this assay was temperature of array centrifugation (4, 12 and
20 ◦C) (Figure 3.4). The best imaging results were obtained with a centrifugation temperature
step of 12 ◦C. Other temperatures, in particular 20 ◦C, reduced the percentage of imageable
cells.
The above data indicated therefore that cells fixed in 3.7% formaldehyde for 1 hour at room
temperature, washed in MilliQ water or 1X PBS, and printed onto poly-L-lysine-coated slides
using a High Throughput Automated Microarrayer (MicroGrid) produced the best imaging
results. Imaging could be improved by centrifuging the slides at 1500 x g and 12 ◦C for 5
minutes, washing in 1X PBS, and mounting in appropriate media. This produces definitive
slide preparations that can be imaged by fluorescence microscopy multiple times.
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Figure 3.4: Effect of the temperature of array centrifugation on cell imaging quality.
Data represent the mean ± s. d. of 5 independent spots (∗p<0.05 One-way analysis of variance
post Tukey's Multiple Comparison test with CI 95%).
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3.2.2 Effect of cell density on imaging
In order to optimize the printing process we have also tested the density of cells in the
printing master plates. For this, we used multiwell plates (384 wells) and 1.26x109 cells/ml
(in MilliQ water) as the starting printing solution, followed for 7 serial 1:2 dilutions.
Only the spots printed from wells containing 1.26x109 cells/ml and 5.14x108 cells/ml pro-
duced imageable cells on the array (Figure 3.5). The percentage of imageable cells printed
from 1.26x109 cells/ml or 5.14x108 cells/ml stocks was similar, but the number of cells in each
printed spot was lower in the latter case (Figure 3.6). This suggested that cell density should
be approximately 109 to obtain the best results (Figure 3.7).
Figure 3.5: Effect of cell density on the percentage of imageable cells on the array.
For printing purposes, cell stocks were prepared in 384-well plates at various densities and
printed directly onto the glass slides. Data represent the mean ± s. d. of 3 independent
spots. The medians do not vary significantly in each initial well (Kruskal-Wallis post Dunn's
Multiple Comparison test with CI 95%).
Starting with stocks of 109 cells/ml allowed us to obtain an average of 500 cells per spot
on the array (Figure 3.6). Increased spot cell density resulted in overlapping of cells, which
reduced the number of cells that could be imaged.
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Figure 3.6: Effect of cell density on the total number of imageable cells on the
array. For printing purposes, cell stocks were prepared in 384-well plates at various densities
and printed directly onto the glass slides. Data represent the mean ± s. d. of 3 independent
spots. The medians do not vary significantly in each initial quantity of well (Kruskal-Wallis
post Dunn's Multiple Comparison test with CI 95%).
Figure 3.7: Effect of cell density on imaging quality. For printing purposes, cell stocks
were prepared in 384-well plates at various densities and printed directly onto the glass slides.
A) Image of a spot printed from a 1.26x109 cells/ml stock; B) Image of a spot printed from a
5.14x108 cells/ml stock.
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3.2.3 Aging of the cell arrays and fluorescence quality
In routine DNA-microarrays, poly-L-lysine coated slides are used after 2 weeks to 1 month
post-coating, to allow the surface to become sufficiently hydrophobic [60]. In contrast, for
cells-arrays, Narayanaswamy and colleagues (2006) suggested that only freshly prepared slides
can be used for each printing run. Since the hydrophobicity is also important to promote
electrostatic interactions between poly-L-lysine and the yeast cell wall, we performed an assay
using commercial poly-L-lysine slides (aged) and freshly coated poly-L-lysine (1 and 10 mg/ml)
slides (Figure 3.8). Our data showed higher percentage of imageable cells in aged (8 days)
slides, and the difference was statistically significant for slides coated with 1 mg/ml of poly-
L-lysine.
Figure 3.8: Effect of aging of slides coating on cell imaging. Data represent the mean
± s. d. of 5 independent spots. (∗p<0.05 and ∗∗p<0.01 One-way analysis of variance post
Tukey's Multiple Comparison test with CI 95%).
We have also tested the effect of aging on the fluorescence of printed slides (8 days, 3 weeks,
and/or 1 month after printing) (Figures 3.9-3.13). The fluorescence in 3 types of poly-L-lysine
slides was compared and in all cases there was a decrease in fluorescence over time.
Figure 3.9: Effect of aging on the fluorescence of printed slides. Commercial poly-
L-lysine was used for this assay. Data represent the mean ± s. d. of 3 independent
spots. For statistical analysis, Kruskal-Wallis post Dunn's Multiple Comparison test with CI
95% was performed and medians don't vary significantly (Printing day: s. d. = 1.060; 8 days
post-printing: s. d. = 0.5327; 1 month post-printing: s. d. = 0.4561).
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Figure 3.10: Effect of aging on the fluorescence of printed slides. Slides coated with
1 mg/ml of poly-L-lysine were used in this assay. The printing and coating were done
in the same day. Data represent the mean ± s. d. of 3 independent spots. For statistical
analysis, Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95% was performed
and medians don't vary significantly (Printing day: s. d. = 1.138; 8 days post-printing: s. d.
= 0.3075; 1 month post-printing: s. d. = 0.1848).
Figure 3.11: Effect of aging on the fluorescence of printed slides. Slides coated with
1 mg/ml of poly-L-lysine were used in this assay. Printing step was done 8 days post-
coating. Data represent the mean ± s. d. of 3 independent spots. For statistical analysis,
Mann Whitney test with CI 95% and the medians are significantly different (Printing day: s.
d. = 0.3636; 3 weeks post-printing: s. d. = 0.2601).
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Figure 3.12: Effect of aging on the fluorescence of printed slides. Slides coated with
10 mg/ml of poly-L-lysine are used in this assay. The printing and coating were done
in the same day. Data represent the mean ± s. d. of 3 independent spots. For statistical
analysis, Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95% was performed
and medians vary significantly (Printing day: s. d. = 0.5801; 8 days post-printing: s. d. =
0.9074; 1 month post-printing: s. d. = 0.5813).
Figure 3.13: Effect of aging on the fluorescence of printed slides. Slides coated with
10 mg/ml of poly-L-lysine are used in this assay. Printing step was done 8 days post-
coating. Data represent the mean ± s. d. of 3 independent spots. For statistical analysis,
Mann Whitney test with CI 95% and the medians aren't significantly different (Printing day:
s. d. = 1.030; 3 weeks post-printing: s. d. = 0.5576).
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3.2.4 Effect of strain genotype and growth conditions on cell adhesion
In order to clarify if the strain genotype was relevant for the efficient production of yeast
arrays we have carried out an assay using different yeast strains grown in 2 different media:
rich (YPD) and minimal medium (Figure 3.14). Imageable cell spots were obtained with all
strains tested (Figure 3.14), however significant differences in the percentage of cells per spot
were observed. This suggests that for optical imaging printing conditions may have to be
optimized for each strain and growth medium.
Figure 3.14: Effect of strain genotype and growth media on cell printing. Data
represent the mean ± s. d. of 5 independent spots for each medium (∗p<0.05 Two-way RM
ANOVA post Bonferroni's test with CI 95% and ∗p<0.05 and ∗∗p<0.01 One-way analysis of
variance post Tukey's Multiple Comparison test with CI 95% to compare strains in YPD
medium).
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3.3 Discussion
As for DNA and proteins, cell-arrays are being developed for high content genetic screens,
whose applications range from basic research to biomedicine. The starting point for these
techniques is the ability to immobilize cells, cell lysates and molecules on solid surfaces. For
DNA and protein microarrays, there is a rising number of slides surfaces. However, the
immobilization of cells is more complex and less developed due to difficulties associated to the
complexity of the cell membrane and cell wall that contain many types of molecules, namely,
proteins, lipids, sugars, etc. [60]. Indeed, the yeast cell wall represents 15 to 30% of the cell dry
weight and is formed by three main groups of polysaccharides: polymers of glucose (β-glucan,
60% of the cell wall dry mass), polymers of mannose (mannoproteins, 40% of the cell dry
mass) and polymers of N-acetylglucosamine (chitin, 2% of the cell dry mass) [2]. Moreover,
the linkage of the other constituents of the cell wall (inner and outer walls) occurs through
branched β-1,6 glucan. The β-1,3 glucan-chitin complex is the major component of the inner
wall, while mannoproteins are on the outer surface of the wall and are extensively O and N
glycosilated. In other words, the yeast cell walls has an anionic surface due to the presence
of negatively charged phosphate groups in the carbohydrate side-chains, and these glycans
form helical (β-1,3 glucan) and ribbon-like (chitin) structures that have non-hydrogen ring
constituents in an equatorial position [49].
For the production of yeast cell-arrays, the substrates described in the literature are poly-
L-lysine and concanavalin-A. The first substrate promotes adherence of yeast cells by elec-
trostatic interactions [62, 60], while the second takes advantage of the binding of lectin to
mannose residues in the yeast cell wall [62]. We have tested 3 additional substrates that are
normally used for the production of protein microarrays: Thermo Scientific∗ Superfrost Plus
Gold Slides, SuperEpoxy 2 slide and Hydrogel-coated substrate.
Superfrost Plus Gold Slides are specifically designed for frozen tissue sections, but our
results showed that this surface does not bind yeast cells efficiently (Figure 3.1 and Figures
A.9 and A.10, Appendix A). Even when using different cells suspension buffers and different
solutions to wash the slides after printing.
SuperEpoxy Substrates and NEXTERION® Slide H are usually used for printing protein-
microrrays due to their capacity to bind proteins covalently. In the first case, epoxy groups
bind to primary amines, thiol and/or hydroxyl groups of proteins. In the second case, slides
are coated with a cross-linked polymer layer activated with N-Hydroxysuccinimide (NHS)
esters, which react irreversibly with the terminal amino of amino-modified nucleic acids and
glycans. Our data showed poor binding of yeast cells to these slides (Figure 3.1 and Figures
A.5-A.8, Appendix A). However, hydrogel-coated slides were slightly better than the others,
probably because this substrate can also react with glycans that are abundant in the yeast
cell wall, whereas SuperEpoxy substrates only react with proteins.
Our best results were obtained with Concanavalin-A and Poly-L-Lysine-coated slides pre-
pared in house (Figure 3.1 and Figures A.1-A.4, Appendix A). For concanavalin-A-coated
slides, efficient cell binding was obtained by washing the slides with MilliQ water, whereas the
best results with poly-L-lysine-coated slides were the obtained by washing slides with 1X PBS.
This was somewhat expected because the concanavalin-A lectin binds to mannose, which is
abundant in the yeast cell wall, while poly-L-lysine is a positively charged amino acid polymer
and the yeast cell wall has an anionic surface, allowing for strong electrostatic interactions to
occur between the two surfaces [2, 49, 62, 60].
Conversely to what is described in the literature [62], glycerol and sorbitol produced poor
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binding results in all slides and conditions tested (Figure 3.1 and Figures A.1-A.10, Appendix
A), while MilliQ water, PBS and MM produced the best results. Glycerol increased viscosity
and lowered evaporation producing spots with regular shape, but decreased binding strongly
due to its hydrophobic properties.
Considering all variables, including the price of commercial slides (Figure 3.15), we con-
clude that the poly-L-lysine-coated slides (1 mg/ml) produced in house are the best for pro-
ducing cell-arrays.
Figure 3.15: Comparative analysis of the price of microarrays slides.
The higher percentages of imageable cells was obtained when slides were washed with
PBS, which is isotonic and non-toxic to the cells (Figure A.22, Appendix A). In contrast,
lower percentages of imageable cells were obtained when the slides were washed with 95%
ethanol (Figure A.23, Appendix A).
Cell-arrays are a high-throughput technique to perform large scale genetic screens. We have
used a GFP-Hsp104 reporter to test whether we could use our cell arrays to detect protein
aggregates. Fixed or non-fixed yeast cells were used and our data clearly shows that live cells
displayed a higher percentage of GFP labelled foci in definitive preparations (Figure 3.3).
This was not observed in live cells in fresh preparations, without mounting media, suggesting
that the mounting media stressed cells and promoted formation of protein aggregates. In
other words, one should be careful when preparing the yeast cell arrays for proteotoxic stress
analysis to avoid introducing artefacts due to the cell preparation protocol.
The overall data shows that the best protocol for producing yeast cell-arrays is the fol-
lowing: yeast cells grown in MM/YPD at 30 ◦C until culture reaches 109 cells/ml; yeast cells
should be fixed with 3.7% formaldehyde for 1 hour at room temperature and washed (2x) in
MilliQ water. Cells should be printed onto poly-L-lysine-coated slides (1 mg/ml) using a High
Throughput Automated Microarrayer (MicroGrid). After printing slides should be centrifuged
at 1500 x g and 12 ◦C for 5 minutes, washed in 1X PBS and mounted using Fluoroshield™
mounting media.
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Chapter 4
Proteotoxic Stress
4.1 Overview
Cells respond to changes in environmental conditions that disturb their normal physiology
or threaten their survival. The response and adaptation to stress involves complex mechanisms
that lead to regulation of cell growth and proliferation, adjustments of gene expression and
metabolic activity. These adaptations are necessary to protect cells from the detrimental
effects of stress and to allow for repairing damaged cellular components [32].
Some stressors induce accumulation of aggregated proteins that trigger a proteotoxic stress
response [27, 54].
Cells respond to protein aggregation by inducing and/or up-regulating the expression of
molecular chaperones which help refolding or degrading aggregated proteins [32]. The chap-
erone genes induced as part of the environmental stress response include small heat shock
proteins (HSP12, HSP26, and HSP48), members of the Hsp70 family of chaperones (SSA4,
SSE2, HSP78), and Hsp104. The latter is an ATPase that dissociate aggregated proteins (dis-
aggregase), allowing Hsp70 chaperones to bind and refold them back into native and functional
conformations [17, 30, 32, 63, 72]. Denatured proteins that cannot be refolded are targeted for
degradation through the ubiquitin-proteasome pathway [30, 32], which also plays a role in the
alteration of the cellular protein content during stress adaptation. The efficient elimination of
potentially toxic proteins is an important selective advantage, and the inability to do so can
lead to disease, in particular to neurodegenerative diseases [54].
Many studies have already been carried out on the yeast stress response to understand
mechanisms of stress adaptation. In this chapter, we investigate the role of various chemical
stressors in the formation of protein aggregates in yeast. We also use ribosomal infidelity
to destabilize the proteome in order to accelerate the formation of protein aggregates in the
absence of environmental stress.
4.2 Results
4.2.1 Mistranslation induces protein aggregation
In order to destabilize the yeast proteome we have used a series of mutant tRNAs that
misincorporate serine at 19 non-cognate codons. This mutagenises proteins on a global scale,
decreasing their stability and folding rate. We then compared the toxicity of the mutant
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tRNAs in vivo in yeast BY4743 strain co-transformed with a GFP-Hsp104 reporter system.
As mentioned before, Hsp104 is a disaggregase and its induction and cellular distribution are
indicative of increased protein aggregation in the cell [17, 83]
Yeast cells expressing the Hsp104-GFP reporter system and transformed with the mutant
tRNAs genes were printed onto an array, using the optimized protocol of cell-arrays production
described previously. The slide array was analyzed by epifluorescence microscopy in order to
detect protein aggregates (Figure 4.1). The number of cells containing GFP fluorescence foci
was quantified and data showed significant increase in localized Hsp104-GFP in cells expressing
tRNASer (Gln) (∗), tRNASer (Glu) (∗∗), tRNASer (Ser), tRNASer (Leu), tRNASer (Thr), tRNASer
(Val), tRNASer (Ala), tRNASer (Gly), tRNASer (Arg), tRNASer (His), tRNASer (Asn), tRNASer
(Met), and tRNASer (Pro) (∗∗∗) relative to control (pRS315) (Figure 4.2).
Figure 4.1: Gene mistranslations induce formation of protein aggregates. Yeast
cells expressing the Hsp104-GFP reporter protein were transformed with pRS315 (A and C),
tRNAUGA(Ser)Ser and mistranslating tRNASer (B and D: tRNACAG(Leu)Ser). Cells were allowed to
grow to middle exponential phase, were fixed with 3.7% formaldehyde, printed on an array and
were observed by fluorescence microscopy (63X objective). Cells expressing the tRNACAG(Leu)Ser
showed localized Hsp104-GFP fluorescence, indicating the presence of protein aggregates.
Besides the total number of cells with protein aggregates in each array spot, other char-
acteristics were studied, namely, the size of the aggregates and the number of aggregates per
cell. The data show that each type of mistranslation has slightly different phenotypes in terms
of protein aggregation (Figures 4.3 and 4.4).
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Figure 4.2: Effect of mistranslation on the formation of protein aggregates. The plots
show the percentage of yeast cells containing localized Hsp104-GFP fluorescence foci. Results
are expressed as the percentage of positive cells (with Hsp104-GFP foci) per cell array spot.
Data represent the mean ± s. d. of three independent spots from arrays (∗∗∗p<0.001, ∗∗p<0.01,
∗p<0.05 one-way Anova post Dunnett's multiple comparison test with CI 95% relative to
pRS315).
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Figure 4.3: Heat-map representing the number of protein aggregates per cell. Yeast
cells containing localized Hsp104-GFP fluorescence foci were counted and differentiated ac-
cording to the number of localized Hsp104-GFP fluorescence foci per cell. Results are expressed
as the percentage of positive cells (with Hsp104-GFP foci) relative to the total number of cells
with protein aggregates per spot. Data represent the mean of three independent spots from
arrays.
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Figure 4.4: Heat-map representing the different types of aggregates produced by
misreading. Yeast cells containing localized Hsp104-GFP fluorescence foci were counted and
differentiated according to the size of localized Hsp104-GFP fluorescence foci per cell. Results
are expressed as the percentage of positive cells (with Hsp104-GFP foci) relative the total
number of cells with protein aggregates per array spot. Data represent the mean of three
independent spots from arrays. S − small protein aggregates; I − intermediate protein aggregates;
L − large protein aggregates.
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4.2.2 Chemical stressors induce protein aggregation
In order to better understand the effects of known chemical stressors in the cell, we per-
formed an assay where yeast cells (BY4743 S. cerevisiae strain) were exposed to specific
stressors. Protein aggregation was then monitored using the Hsp104-GFP reporter protein
described above. Cells were grown in presence of different stress conditions (Table 2.3), dur-
ing 20 hours, and were then printed onto a cell array, according to the optimized protocol of
cell-arrays described previously. The slide array was analyzed by epifluorescence microscopy
in order to detect protein aggregates (Figure 4.5). The data showed significant increase in lo-
calized Hsp104-GFP in cells grown in presence of calcium chloride (0.5 M), cadmium chloride
(100 µM), chromium trioxide (0.5 mM), geneticine (75 mg/l and 200 mg/l), lithium chloride
(150 mM and 300 mM), magnesium chloride (1 M), menadione (150 µM) and high temper-
ature (37 ◦C). Our data showed that cells exposed to different chemical stressors produce
different types of aggregates (Figures 4.7 and 4.8).
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Figure 4.5: Effect of chemical stressors on protein aggregation. The plots show the
percentage of yeast cells with protein aggregates (localized Hsp104-GFP fluorescence foci)
that were exposed to 32 different chemical conditions. Results are expressed as the percentage
of positive cells (with Hsp104-GFP foci) relative to the total number of cells per spot. Data
represent the mean ± s. d. of three independent clones, obtained from three different spots
from arrays. For statistical analysis, One-way analysis of variance test was performed and
means are significantly different from control (normal growth), p<0.0001.
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Figure 4.6: Relative quantification of total fluorescence in cells exposed to different
chemical stressors. Total fluorescence of Hsp104-GFP fusion protein expressed in yeast
cells exposed to 32 different chemical conditions was quantified using Image J. Data represent
the mean of three independent clones relative to the control (intensity = 0; normal growth
condition). One-way analysis of variance test was performed and means are significantly
different from control (normal growth), p<0.0001.
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Figure 4.7: Heat-map representing the number of protein aggregates per cell ex-
posed to chemical stressors. Yeast cells containing localized Hsp104-GFP fluorescence foci
were counted and differentiated according to the number of localized Hsp104-GFP fluorescence
foci per cell. Results are expressed as the percentage of positive cells (with Hsp104-GFP foci)
relative to the total number of cells with protein aggregates per spot. Data represent the mean
of three independent clones, obtained from three different array spots.
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Figure 4.8: Heat-map representing different types of aggregates in yeast cells ex-
posed to chemical stressors. Yeast cells containing localized Hsp104-GFP fluorescence foci
were counted and differentiated according to the size of localized Hsp104-GFP fluorescence
foci. Results are expressed as the percentage of positive cells (with Hsp104-GFP foci) rela-
tive to the total number of cells with protein aggregates per array spot. Data represent the
mean of three independent clones, obtained from three different array spots. S − small protein
aggregates; I − intermediate protein aggregates; L − large protein aggregates.
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4.3 Discussion
Our data show that mistranslation induces formation of protein aggregates. In particular
tRNAs that misincorporated serine at leucine, threonine, valine, alanine, glycine, arginine,
histidine, glutamic acid, asparagine, glutamine, methionine, and proline codons had a strong
impact on protein aggregation (Figure 4.2). In fact, the misincorporation of serine in general
destabilizes protein structure and should have promoted the synthesis of misfolded or unfolded
proteins that aggregated. Depending on the properties of the substituted amino acid (Figure
4.9), the misincorporations of serine likely lead to more or less extensive protein aggregation.
Figure 4.9: Venn diagram with the classification of the physical and chemical prop-
erties of amino based on [82]. Adapted from [51].
From a theoretical point of view the amino acids substitution matrix BLOSUM 62 [31]
(Figure 4.10) provides important information regarding the likelyhood of protein aggregation.
This matrix classifies amino acids according to their tendency to be exchanged by other
amino acid in proteins. This matrix was built from large sets of protein alignments sequences
by counting the number of times that a specific substitution occurs and comparing this to
what would be expected by random substitutions. In this way, high values indicate that a
substitution occurs often in nature and so is favorable, and vice versa [7].
Substitution of aliphatic amino acids (Leu, Ile, and Val) for Ser has a value of -2, indicating
that this is a rare event. This is expected because these amino acids have a hydrophobic nature
and non-reactive side chains and are normally buried in protein hydrophobic cores, while Ser
is a small polar amino acid containing a reactive hydroxyl group and is located on proteins
surface [7]. In other words, it is likely that misincorporation of Ser at Leu, Ile and Val codons
will disrupt protein structure, leading to misfolding and protein aggregation. Indeed, the
misincorporation of Ser at Leu codons produced the highest percentage of protein aggregates
in our assay (Figure 4.2). The misincorporation of Ser at Ile and Val codons also produced
protein aggregates, but at lower level than Leu. However, the misincorporation of Ser at Ile
and Val codons promoted the formation of more than four protein aggregates per cell (Figure
4.3). These data are in line with previous studies which show that Val/Thr substitutions cause
protein denaturation [61].
The substitution of Phe and Tyr have a value of -2 and Trp has a value of -3 in the
substitution matrix BLOSUM 62. These amino acids have an aromatic side chain and are
buried in protein hydrophobic cores [7]. Therefore, one expected that misincorporation of Ser
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Ala 4
Arg -1 5
Asn -2 0 6
Asp -2 -2 1 6
Cys 0 -3 -3 -3 9
Gln -1 1 0 0 -3 5
Glu -1 0 0 2 -4 2 5
Gly 0 -2 0 -1 -3 -2 -2 6
His -2 0 1 -1 -3 0 0 -2 8
Ile -1 -3 -3 -3 -1 -3 -3 -4 -3 4
Leu -1 -2 -3 -4 -1 -2 -3 -4 -3 2 4
Lys -1 2 0 -1 -3 1 1 -2 -1 -3 -2 5
Met -1 -1 -2 -3 -1 0 -2 -3 -2 1 2 -1 5
Phe -2 -3 -3 -3 -2 -3 -3 -3 -1 0 0 -3 0 6
Pro -1 -2 -2 -1 -3 -1 -1 -2 -2 -3 -3 -1 -2 -4 7
Ser 1 -1 1 0 -1 0 0 0 -1 -2 -2 0 -1 -2 -1 4
Thr 0 -1 0 -1 -1 -1 -1 -2 -2 -1 -1 -1 -1 -2 -1 1 5
Trp -3 -3 -4 -4 -2 -2 -3 -2 -2 -3 -2 -3 -1 1 -4 -3 -2 11
Tyr -2 -2 -2 -3 -2 -1 -2 -3 2 -1 -1 -2 -1 3 -3 -2 -2 2 7
Val 0 -3 -3 -3 -1 -2 -2 -3 -3 3 1 -2 1 -1 -2 -2 0 -3 -1 4
Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Met Phe Pro Ser Thr Trp Tyr Val
Figure 4.10: Amino acids substitutions matrix: BLOSUM 62. Adapted and modified
from [31].
at Phe, Tyr and Trp codons would also increase misfolding and protein aggregation. However,
our data showed that Ser misincorporation at these codons did not result in significant protein
aggregation (Figure 4.2). Interestingly, the substitution of Tyr and Trp for Ser lead to the
formation of more than four protein aggregates per cell, in most of the cells. Additionally,
the substitution of Tyr for Ser produced large protein aggregates occupying most of the cell
cytoplasm (Figures 4.3 e 4.4).
A value of -1 in the substitution matrix BLOSUM 62 is also indicative of rare substitutions
and represents misincorporation of Ser at Arg, Cys, His, Met and Pro codons. Our data
showed that substitution of these amino acids with Ser, except for Cys with Ser, resulted in
higher percentage of cells with aggregates relative to control (Figure 4.2). Although, arginine
and serine are polar amino acids, arginine is positively-charged and is frequently involved in
salt-bridges. It also forms hydrogen bonds with negatively charged amino acids that can be
important for protein stability [7]. In other words the substitution of Arg with Ser decreases
protein stability, leading to unfolded or misfolded proteins and protein aggregation. Similarly,
histidine is a polar amino acid whose substitution by other amino acids is problematic, in
particular because it has a pKa near physiological pH and may alter the charge of the side chain
from neutral to positive in response to small alterations in intracellular pH [7]. Proline also has
unique chemical properties and its replacement normally leads to protein instability. Its side
chain is crucial for the native secondary structure of proteins. So, replacement of both His and
Pro with Ser are likely to unfold proteins, promoting their aggregation. Methionine, like the
other hydrophobic amino acids referred before, is normally buried in protein hydrophobic cores
and, so, it is likely that misincorporation of Ser at Met positions leads to protein misfolding
and aggregation. Interestingly, cells tolerate relatively well substitutions of Cys with other
small amino acids, namely serine [7], which explains the lack of protein aggregation in cells
misincorporating Ser at Cys codon in our assay.
The misincorporation of Ser at Gly, Glu and Gln codons has a BLOSUM 62 matrix value of
zero, indicating that these substitutions occur often in nature and have little impact on protein
structure. However, our data indicates that these replacements increase protein aggregation,
but to a lesser extent than the replacements described before (Figure 4.2). Interestingly, our
data show that misincorporation of Ser at Lys and Asp codons has little impact on protein
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aggregation, which is in agreement with the value (0) given by the BLOSUM 62 matrix
(Figures 4.2 e 4.10), and with their shared polar properties (Figure 4.9).
Substitution of Ala with Ser has value BLOSUM 62 of 1 and is generally viewed as having
little impact on protein structure [26, 74]. However, mischarged Ser-tRNAAla and Gly-tRNAAla
up-regulate cytoplasmatic chaperones and induce the unfolded protein response [26, 74], which
is in line with our GFP-Hsp104 fluorescence data (Figure 4.2). Finally, replacement of Thr
and Asn with Ser are common in nature and have a BLOSUM 62 matrix value of 1. But, our
data indicates that they cause proteotoxic stress in yeast cells (Figure 4.2) and more studies
are needed to explain the toxicity produced by these amino acids substitutions.
The role of environmental stress on protein aggregation is still poorly understood [32],
however some stressors such as heat and ethanol have a strong effect on protein misfolding
and aggregation. For example, ethanol is known to bind protein sites, displace water molecules
and alter protein structure, leading to protein aggregation [19]. In our study exposure to 2%
and 5% of ethanol resulted in lower levels of protein aggregation than those observed in control
cells grown without ethanol (Figure 4.5). This may be explained by the natural resistance of
yeast to ethanol since the latter is a natural product of glucose fermentation.
Toxic metals are environmental pollutants which are linked to a broad range of degenerative
conditions in humans [33]. The effect of these metals in growth and metabolic activities is
well documented [81], however the molecular mechanisms of metals toxicity is still poorly
understood. We have tried to understand the effect of arsenic, cadmium, copper, chromium,
lithium, magnesium on protein aggregation.
Chromium is an environmental pollutant that can cause genotoxicity, carcinogenicity and
allergenicity. How it does so is not yet clear but one hypothesis is that Cr toxicity is caused by
increased production of reactive oxygen species (ROS) and protein oxidation [33, 81], leading
to accumulation of toxic protein aggregates [33]. Our data support this hypothesis since
protein aggregates increased significantly in cells exposed to chromium (Figure 4.5).
Cadmium inhibits enzymes involved in detoxification of ROS, with consequent cellular
accumulation of ROS [44, 54]. Cadmium can also replace Fe+2 in proteins, producing oxygen
radicals due to the release of Fe+2 [54]. This can lead to protein structure destabilization, and
our data showed that the percentage of cells with protein aggregates increased in the presence
of cadmium chloride (100 µM) (Figure 4.5).
Copper toxicity is associated with oxidative stress in neurodegenerative diseases and there
is some evidence that it may impair hsp70 function, which is critical for protecting cells from
proteotoxicity [84]. Our data shows that cells exposed to copper sulfate have lower levels
of protein aggregates and expression of hsp104 is lower than that observed in control cells
(normal growth conditions) (Figure 4.5).
Similarly, arsenite may also destabilise proteins through increased ROS production [84].
But, our data showed that cells exposed to arsenic trioxide produced lower levels of protein
aggregates than the control cells (normal growth conditions) (Figure 4.5). Therefore, addi-
tional studies are required to clarify the association of ROS and protein aggregation mediated
through arsenite ions.
Our data showed that lithium and magnesium chloride increased the percentage of cells
containing protein aggregates (Figure 4.5). To our knowledge this is the first time that lithium
and magnesium chloride have been shown to increase formation of protein aggregates. The
only indirect evidence for a role of Li2+ and Mg 2+ in protein aggregation is the up-regulation
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of the expression of Hsp26 in cells exposed to Li2+ and the up-regulation of SSA1 and SSA2
in cells exposed to Mg2+ [34]. Additionally, cells exposed to magnesium chloride showed more
than one protein aggregation foci per cell, in more than 80% of the cases (in normal growth
conditions cells had one aggregate per cell in 50% of the cases, only) (Figure 4.7).
Guanidine hydrochloride (GuHCl) is a chaotropic salt that promotes protein denatura-
tion [17, 27, 63]. High concentration of this denaturant unfolds almost all proteins through
disruption of intra- and inter-molecular interactions [27]. Additionally, GuHCl promote the
expression of the stress protein Hsp104 [17]. However, our data showed that cells exposed to
guanidine hydrochloride had lower levels of protein aggregates and hsp104 than the control
cells (normal growth conditions) (Figure 4.5). GuHCl can also have adverse effects on the
ATPase activity of Hsp104 [17, 63]. Since our system to quantify protein aggregation was
based on the interaction of the molecular chaperone hsp104 with the aggregates one cannot
exclude the hypothesis that GuHCl inhibits hsp104 activity. Interestingly, in cells exposed to
GuHCl, protein aggregates were larger that in the other stressors (Figure 4.8).
DTT is a reducing agent that promotes reductive stress and can increase the cellular levels
of misfolded proteins [69]. Our results show however that DTT reduces the relative percentage
of cells with protein aggregates (Figure 4.5). However, reductive stress due to DTT can lead
to accumulation of misfolded proteins in the ER which triggers the unfolded protein response
(UPR) [69], with consequent up-regulation of BiP; an ER protein involved in the translocation,
folding, and assembly of secretory and transmembrane proteins [42].
Oxidative stress is known to increase protein aggregation, we have exposed our yeast
cells to menadione, hydrogen peroxide and paraquat and we could confirm increased protein
aggregation in presence of menadione (150 µM), but we could not confirm the presence of
protein aggregates in cells exposed to H2O2 (Figure 4.5), suggesting that H2O2 may increase the
breakdown of unfolded or misfolded proteins preventing them from entering the aggregation
pathway.
Paraquat is a bipyridinium salt used as an herbicide, but with toxic effects on microor-
ganisms, animals and humans. It is a superoxide generator and its toxicity as been linked
to ROS accumulation with consequent damage of proteins [54]. Inhibition of yeast growth
has also been reported [28], but very little is known about its effects on protein aggregation.
Nevertheless, paraquat has been shown to cause aggregation of α-synuclein and formation of
Lewy bodies [52], which are characteristic of Parkinson's disease. We were not able to confirm
the increased production of protein aggregates in cells exposed to paraquat (Figure 4.5).
The effect of ionic/osmotic stress in protein aggregation was also tested in this study using
calcium, sodium, and potassium chloride. Although, at low concentrations, they can stabilize
proteins via non-specific electrostatic interactions, at high concentrations, salts can stabilize
or destabilize proteins, or even denature proteins, depending on the types and concentration
of the salts [27]. In fact, high concentration of inorganic ions, such K+, Na+, and Cl-, disrupt
enzyme activity and destabilize protein secondary structure, leading to protein aggregate
formation due to non-native protein-protein interactions [11]. High salt concentrations, mainly
Na+ and K+, elicits the osmostress response, which is similar to the general stress/heat shock
protein responses, induced by accumulation of misfolded or improperly assembled proteins
in the ER [46]. Again, our cells exposed to NaCl and KCl did not show an increase in the
percentage of protein aggregates relative to non-stressed cells (Figure 4.5), probably because
the concentration used was too low to trigger protein aggregation.
Calcium-induced aggregation has been described and it can have a role in the storage of
regulated secretory proteins in secretory granules [36]. Our data confirms previous studies
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since cells exposed to calcium chloride (0.5 M) produced higher levels of protein aggregates
than control cells (Figure 4.5).
Finally, caffeine (1,3,7-trimethylzanthine) was also tested. Caffeine is an analogue of purine
bases and has pleiotropic effects in the cell [45]. Our results show that cells exposed to caffeine
have lower percentage of protein aggregates than the control cells (Figure 4.5). Interestingly,
GFP-Hsp104 total fluorescence was higher in cells exposed to caffeine than in control cells
(Figure 4.6), indicating that caffeine may promote formation of small aggregates that are
dispersed in the cytoplasm. Additional studies are therefore needed to clarify this interesting
observation. Similarly, cells exposed to SDS (or sodium dodecyl sulfate) showed lower per-
centage of protein aggregates (Figure 4.5), but increased level of total fluorescence (Figure
4.6). Since SDS is an anionic detergent that binds to hydrophobic regions of polypeptides, it
helps solubilizing denaturated proteins dispersing them in the cytoplasm [27].
4.4 Conclusion and Future Work
Our main goal was to develop a yeast cell-array for high-throughput genetic screens. We
have optimized the technology for producing high density cell arrays and, as a proof-of-
principle, used them to screen chemical and genetic cues that promote the formation of protein
aggregates. As one would expect, our data showed that mistranslation and various chemical
stressors induce protein aggregation, as monitored by increased expression and localization of
the Hsp104 disaggregase.
Our technology is robust, but it will be necessary to automate acquisition of images and
establish a computational pipeline for analysis. Simultaneously, integration of robotic tools
must be done to produce large-scale data sets for setting up genetic screens. Such tools
would allow us to use our cell array technology to identify chemical stressors that cause
proteotoxic stress, which is relevant to understand the role of environmental factors in protein
conformational diseases.
Since Saccharomyces cerevisiae proteins have high homology with higher eukaryotic pro-
teins, yeast can be used to elucidate the molecular biology of proteotoxic stress. Our technol-
ogy can therefore be applied to study the molecular mechanisms of human diseases associated
to protein misfolding and aggregation, using yeast cell arrays.
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Figure A.1: Percentage of imageable cells printed on poly-L-lysine coated slides.
Cells were fixed with 3.7% prior to printing. Data represent the mean ± s. d. of 3 inde-
pendent spots. The medians were calculated using the Kruskal-Wallis post Dunn's Multiple
Comparison test with CI 95%.
Figure A.2: Percentage of imageable cells printed on poly-L-lysine coated slides.
Cells were not fixed prior to printing. Data represent the mean ± s. d. of 3 independent
spots. The medians were calculated using the Kruskal-Wallis test with CI 95%.
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Figure A.3: Percentage of imageable cells printed on concanavalin-A coated slides.
Cells were fixed prior to printing. Data represent the mean ± s. d. of 3 independent spots.
The medians were calculated using the Kruskal-Wallis test with CI 95%.
Figure A.4: Percentage of imageable cells printed on concanavalin-A glass slides.
Cells were not fixed prior to printing. Data represent the mean ± s. d. of 3 independent spots.
The medians were calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test
with CI 95%.
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Figure A.5: Percentage of imageable cells printed on SuperEpoxy 2 coated slides.
Cells were fixed prior to printing. Data represent the mean ± s. d. of 3 independent spots.
The medians were calculated using the Kruskal-Wallis test with CI 95%.
Figure A.6: Percentage of imageable cells printed on SuperEpoxy 2 glass slides.
Cells were not fixed prior to printing. Data represent the mean ± s. d. of 3 independent
spots. The medians were calculated using the Kruskal-Wallis test with CI 95%.
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Figure A.7: Percentage of imageable cells printed on Hydrogel-coated slides. Cells
were fixed prior to printing. Data represent the mean ± s. d. of 3 independent spots. The
medians were calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test with
CI 95%.
Figure A.8: Percentage of imageable cells printed on Hydrogel glass slides. Cells
were not fixed prior to printing. Data represent the mean ± s. d. of 3 independent spots.
The medians were calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test
with CI 95%.
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Figure A.9: Percentage of imageable cells printed on Superfrost Plus Gold slides.
Cells were fixed prior printing. Data represent the mean ± s. d. of 3 independent spots. The
medians were calculated using the Kruskal-Wallis test with CI 95%.
Figure A.10: Percentage of imageable cells printed on Superfrost Plus Gold glass
slides. Cells were not fixed prior printing. Data represent the mean ± s. d. of 3 independent
spots (∗p<0.05 Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%). The
medians were calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test with
CI 95%.
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Figure A.11: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on poly-L-lysine coated slides. Cells were fixed with 3.7%
prior to printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%.
Figure A.12: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on poly-L-lysine coated slides. Cells were not fixed prior
to printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis test with CI 95%.
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Figure A.13: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on concanavalin-A coated slides. Cells were fixed prior
to printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis test with CI 95%.
Figure A.14: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on concanavalin-A glass slides. Cells were not fixed prior
to printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%.
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Figure A.15: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on SuperEpoxy 2 coated slides. Cells were fixed prior to
printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis test with CI 95%.
Figure A.16: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on SuperEpoxy 2 glass slides. Cells were not fixed prior to
printing. Data represent the mean ± s. d. of 3 independent spots (∗p<0.05 Kruskal-Wallis
post Dunn's Multiple Comparison test with CI 95%). The medians were calculated using the
Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%.
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Figure A.17: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on Hydrogel-coated slides. Cells were fixed prior to printing.
Data represent the mean ± s. d. of 3 independent spots. The medians were calculated using
the Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%.
Figure A.18: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on Hydrogel glass slides. Cells were not fixed prior to print-
ing. Data represent the mean ± s. d. of 3 independent spots. The medians were calculated
using the Kruskal-Wallis post Dunn's Multiple Comparison test with CI 95%.
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Figure A.19: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on Superfrost Plus Gold slides. Cells were fixed prior
printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis test with CI 95%.
Figure A.20: Percentage of cells with protein aggregates (localized Hsp104-GFP
fluorescence foci) printed on Superfrost Plus Gold slides. Cells were not fixed prior
printing. Data represent the mean ± s. d. of 3 independent spots. The medians were
calculated using the Kruskal-Wallis test with CI 95%.
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Figure A.21: Effect of slide washing with MilliQ water on imaging of fixed yeast
cells. Data represent the mean ± s. d. of 3 independent spots. The medians vary significantly
(Kruskal-Wallis test with CI 95%).
Figure A.22: Effect of slide washing with 1X PBS on imaging of fixed yeast cells.
Data represent the mean ± s. d. of 3 independent spots. The medians vary significantly
(Kruskal-Wallis test with CI 95%).
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Figure A.23: Effect of slide washing with ethanol on imaging of fixed yeast cells.
Data represent the mean ± s. d. of 3 independent spots. The medians vary significantly
(Kruskal-Wallis test with CI 95%).
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Figure B.1: Number of protein aggregates per cell. Yeast cells containing localized
Hsp104-GFP fluorescence foci were counted and differentiated according to the number of
localized Hsp104-GFP fluorescence foci per cell. Results are expressed as the percentage
of positive cells (with Hsp104-GFP foci) relative to the total number of cells with protein
aggregates per spot. Data represent the mean of three independent spots from arrays.
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Figure B.2: Misreading produces different types of aggregates. Yeast cells containing
localized Hsp104-GFP fluorescence foci were counted and differentiated according to the size
of localized Hsp104-GFP fluorescence foci per cell. Results are expressed as the percentage of
positive cells (with Hsp104-GFP foci) relative the total number of cells with protein aggregates
per array spot. Data represent the mean of three independent spots from arrays.
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Figure B.3: Number of protein aggregates per cell exposed to chemical stressors.
Yeast cells containing localized Hsp104-GFP fluorescence foci were counted and differentiated
according to the number of localized Hsp104-GFP fluorescence foci per cell. Results are
expressed as the percentage of positive cells (with Hsp104-GFP foci) relative to the total
number of cells with protein aggregates per spot. Data represent the mean of three independent
clones, obtained from three different array spots.
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Figure B.4: Different chemical stressors induce formation of different types of ag-
gregates in yeast cells. Yeast cells containing localized Hsp104-GFP fluorescence foci were
counted and differentiated according to the size of localized Hsp104-GFP fluorescence foci.
Results are expressed as the percentage of positive cells (with Hsp104-GFP foci) relative to
the total number of cells with protein aggregates per array spot. Data represent the mean of
three independent clones, obtained from three different array spots.
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